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ABSTRACT
EPIDEMIOLOGICAL INVESTIGATIONS OF BIGHORN SHEEP RESPIRATORY
DISEASE AND IMPLICATIONS FOR MANAGEMENT
BRANDI FELTS
2020
Infectious respiratory disease has long been identified as the cause of bighorn
sheep (Ovis canadensis) historical declines and extirpations, and Mycoplasma
ovipneumoniae (Movi) is the primary pathogen inducing disease and mortality.
Population-level effects of pneumonia events range from mild to extirpation. Variable
individual response to pathogen exposure emerges from dynamic interactions between
competing evolutionary processes within the host and pathogen. Understanding impacts
of this evolutionary warfare is essential to assessing long-term impacts of pathogen
invasion and developing appropriate countermeasures to protect population health. Freeranging populations are faced with spillover infections from domestic sheep and goats as
well as previously infected conspecifics. The introduction of a novel Movi strain from a
spillover event can result in high all-age morbidity and subsequent mortality. We studied
the effects of indirect and direct infection of captive bighorn sheep with Movi, a
genetically diverse pathogen. We also used known Movi-carriage histories to classify
ewes into 1 of 3 Movi carrier classes. We tested the hypothesis that respiratory disease
persistence within bighorn sheep populations is driven by chronically Movi infected
ewes, and the prediction that lambs born in pens with at least one chronic carrier ewe
(treatment) would experience Movi-induced pneumonia mortality whereas lambs born in
pens without a chronic carrier ewe (control) would not develop fatal pneumonia. When
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all mortality causes were pooled across all years of our study, the percentage of lambs
that did not survive was more than twice as high when lambs were in born in pens
containing at least one Movi chronic shedder ewe (treatment), compared to when only
Movi negative and/or intermittent ewes were present in the pen (control; 92% (n = 33 of
36) and 38% (n = 5 of 13). The mean probability of pneumonia-induced mortality for
commingled lambs was above 0.75 by 15 days of age and generally remained above that
level for the duration of the study. Our model also estimated this probability to be
elevated (≥ 0.90) as early as 16 days of age until 45 days of age, and a secondary peak for
older, nearly weaned, lambs (105–114 days of age). While conducting a study for Movi
detection probability in serial samples, we document unilateral Movi colonization and
direct managers on field sampling techniques for reliable disease surveillance of bighorn
sheep populations. Our results suggest that active disease control efforts must account
for multiple Movi strains to prevent spillover epidemics. Our results also underscore that
removal of chronic carriers from a population will aid bighorn sheep recovery efforts.

1
CHAPTER 1: INDIVIDUAL BIGHORN SHEEP RESPONSE TO INFECTION BY A
GENETICALLY DIVERSE PATHOGEN: IMPLICATIONS FOR FREE RANGING
POPULATIONS

This chapter is being prepared for publication and was coauthored by Daniel P. Walsh,
Thomas E. Besser, E. Frances Cassirer, and Jonathan A. Jenks.
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ABSTRACT
Variable individual response to pathogen exposure emerges from dynamic
interactions between competing evolutionary processes within the host and pathogen.
The host’s adaptive immune system recognizes pathogens to which it has previous
exposure and mounts a defensive immune response. Pathogens have evolved strategies
to overcome adaptive immune defenses including maintaining high genetic diversity
through rapid evolution. Alteration of surface exposed antigenic epitopes results in
diverse strain types unrecognizable by the immunological memory of the adaptive
immune system. Understanding impacts of this evolutionary warfare is essential to
assessing long-term impacts of pathogen invasion and developing appropriate
countermeasures to protect population health. During an epizootic of respiratory disease,
we had the opportunity to examine impacts of pathogen diversity on individual hosts
using captive bighorn sheep (Ovis canadensis) infected by genetically diverse strains of
Mycoplasma ovipneumoniae (Movi). We monitored clinical signs of 37 bighorns, housed
in nine pens, with previous exposure to known strains of Movi, during an epizootic
dominated by a specific Movi strain. We found higher levels of antibody to Movi prior
to the epizootic were associated with lower likelihood of exhibiting clinical signs of
pneumonia (median of posterior distribution of the antibody levels prior to the outbreak
(Movi %II) = -10.14; 95% CI = -21.79 – -1.40). However, in symptomatic individuals,
higher antibody levels were associated with more severe disease, with increased
probability (median = 3.21; 95% CI = 0.57 – 7.39) and speed of pneumonia-induced
mortality (median = 1.10; 95% CI = 0.18 – 2.23), and reduced likelihood of returning to
an asymptomatic state (median = -2.31; 95% CI = -5.52 – -0.05). Bighorn sheep that had
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previous exposure to a strain other than the dominant epizootic strain were more likely to
recover (median = 5.29 – 6.44; 95% CI = 0.42 – 14.51) suggesting factors other than
adaptive immunity also were important for recovery to an asymptomatic state. Our
results suggest that Movi-strain variability was sufficient to overcome adaptive bighorn
immunological defenses, but cofactors such as pathogen virulence, dose response, and
contact patterns may be important drivers of heterogeneity in response to pathogen
invasion. These finding also suggest that active disease control efforts must account for
multiple strains.

KEY WORDS: bighorn sheep, disease state, hazard, immune response, mortality,
Mycoplasma ovipneumoniae, strain, transmission

INTRODUCTION
Pathogens and their hosts are involved in on-going evolutionary warfare. Many
hosts have evolved immunological defenses including the adaptive immune system,
which the host uses to recognize pathogens to which it was previously exposed and
thereby mounts a rapid immune response to combat infection. Successful pathogens have
evolved various complex and efficient methods to evade, circumvent, or overcome innate
and adaptive host immune defenses, resulting in increased disease severity or duration of
infection of the host (Finlay and McGadden 2006). One subtle but highly successful
mechanism, employed by pathogens to evade adaptive immunity, is rapid evolution
resulting in alteration of surface exposed antigenic epitopes, which leads to multiple and
genetically diverse strain types (Bloom 1979). Pathogen genetic diversity has
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implications for individual host response to infection and ultimately determines the
pathogen’s virulence, transmissibility, and severity of epidemiological outbreaks
(Coscolla and Gagneux 2010, Chae and Shin 2018). Extensive literature describing
antigenic variation within Mycoplasma (class Mollicutes), the smallest and simplest selfreplicating organisms, have been communicated (Christiansen et al. 1997, Citti et al.
2010, Betlach et al. 2019, Qin et al. 2019). Therefore, this variation is of fundamental
importance in determining the underlying dynamics of host–pathogen interactions. We
investigated these host-pathogen interactions by examining the impacts of pathogen
genetic diversity on individual bighorn sheep.
Mycoplasma ovipneumoniae (Movi) is a primary etiologic agent of pneumonia in
bighorn sheep (Besser et al. 2012b, Besser et al. 2013, Cassirer et al. 2018). Movi is a
common pathogen of domestic sheep and goats that exhibits a high degree of genetic
(strain) and phenotypic heterogeneity (Ionas et al. 1991a, b, Parham et al. 2006,
Maksimović et al. 2017, Kamath et al. 2020). Infection of bighorn sheep by Movi,
typically occurs after contact with a live animal reservoir, and is often followed by
epizootic transmission with high pneumonia morbidity affecting all age classes with
variable mortality (Besser et al. 2014, Cassirer et al. 2018). Surviving bighorn sheep
exhibit variable responses to Movi infection. Most sheep clear Movi infections (with
immunity restricted to that strain), although some become chronic carriers which
persistently shed the pathogen in the upper respiratory tract (Cassirer et al. 2017,
Plowright et al. 2017).
Individual host response and resulting dynamics of disease, including severity of
the epizootic, within and among bighorn sheep populations is shaped by heterogeneities
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in Movi strain-specific virulence, Movi infection dosages, and prior Movi exposure
histories. The resulting long-term population-level impacts of exposure to Movi varies
from full recovery to functional or local extinction (Foreyt and Jessup 1982, Singer et al.
2000, Sells et al. 2015).
Describing factors such as exposure history or adaptive immune responses
associated with individual and population variation in disease severity and persistence
addresses an important knowledge gap for mitigating impacts of pneumonia and restoring
bighorn sheep populations. To fill this gap, we used information collected prior to and
during a bighorn sheep pneumonia epizootic within a captive herd to investigate the
heterogeneity in individual disease response in relation to pathogen strain type and
exposure history. We then modeled the effects of pathogen genetic diversity on host
population dynamics based on the observed individual host responses to understand how
these factors may drive epizootics in free-ranging bighorn sheep populations.
METHODS
Study Area
We used information from South Dakota State University (SDSU) Captive
Wildlife Research Facility in Brookings, South Dakota (44°20´ N, 96°47´ W) collected
on 34 bighorn sheep transported from free-ranging populations in Washington (n = 13, 2
populations), Oregon (n = 5), Idaho (n = 2), South Dakota (n = 3) and Nevada (n = 11),
and animals >1 year of age (n = 3) born to the Washington-origin sheep in captivity at
SDSU. Temperature at the study site ranges from -29°C–38°C with a mean annual
temperature of 8°C (Spuhler et al. 1971). Mean regional precipitation ranges from 33–
63.5 cm, including snowfall of 63.5–114 cm (Spuhler et al. 1971). The prevailing wind
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direction is from the south in the spring and the north-northwest during the winter. Wind
speeds can exceed 80.5 km/h; however, the average annual wind speed in the region is
17.7 km/h (Spuhler et al. 1971).
Captive animals were provided fresh alfalfa-grass mixed hay, pelleted soybean
hulls, water, and loose mineral ad libitum daily. Capture, transport, daily care and animal
sampling protocols were reviewed and approved by the SDSU Institutional Animal Care
and Use Committee (Number 14-076A). Captive animal care met or exceeded the
recommendations from the Sikes and Animal Care and Use Committee of the American
Society of Mammalogists (2016).
Source Herds
Uniquely marked free ranging adult bighorn sheep were tested 1 to 7 times to
classify Movi infection status over a period of up to 4 years by state wildlife agencies in
Idaho, Oregon, Washington, Nevada, and South Dakota for this study (Appendix A;
Table 1). Sheep were captured and transported to SDSU. These animals were host to
genetically diverse strains of Movi. Specifically, sheep from the Hells Canyon
subpopulations, Asotin (Washington), Lostine (Oregon), and Sheep Mountain (Idaho),
entered the study with the Movi 404 strain, herein referred to the HC-404 strain. The
Black Butte herd within Hells Canyon carried the HC-404 strain from 1995 until a novel
Movi strain, 393, was detected in 2014 (Cassirer et al. 2017). We refer to this strain as
BB-393/HC-404. Rapid Creek and Badlands herds within South Dakota were exposed to
the SD-398 strain, and the Snowstorm herd from Nevada entered the study with the Movi
400 strain and is therefore referred to as NV-400 herein (Table 1).
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Most sheep were of known Movi infection class and strain type when they arrived
at SDSU and were segregated into pens based on infection status and strain type (Fig. 1).
Sheep of unknown infection status and strain type were penned together by capture event
and segregated from other sheep until their carrier status and strain type were confirmed.
This included sheep that were transferred to SDSU from the Badlands herd (n = 2) in
2012 and the Snowstorm (n = 11) and Black Butte herds (n = 8) in 2014.
Experimental design
Bighorn sheep at SDSU were assigned to pens based on Movi carriage
characteristics using a switch back design with replicates from 7 source populations and 3
sheep born in captivity (Table 1). Sheep were penned together by Movi strain type
exposure and carriage history (chronic carrier in pen or not). We used carriage history as
our initial measure of individual host infection response. A minimum distance of 15 m
between carrier and non-carrier pens was established to minimize the potential for
pathogen transmission between pens. Considering the prevailing winds, bighorn sheep
groups lacking chronic Movi carrier were housed in pens in the western (upwind) edge of
the research facility (Fig. 1).
Further, in an effort to prevent any human-assisted transmission of pathogens,
personnel followed strict biosecurity protocols including: (1) the installation of
disinfecting foot baths at each pen gate for use immediately prior to entering and exiting
each pen; (2) use of pen-specific feed and water pails; (3) changing protective clothing
when handling possible Movi-positive sheep; and (4) use of order-of-entry from west
(Movi-negatives) to east (Movi-positives; Fig. 1).
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Microbiological Sampling
Starting the fall after an individual arrived at the facility, we collected serial
microbiological samples from all sheep from 1 October–15 March annually, or when
dependent lambs were no longer present in each pen. To capture adults for sampling, we
administered chemical immobilizing agents (BAM; 0.43 mg/kg butorphanol, 0.29 mg/kg
azaperone, 0.17 mg/kg medetomidine, Wildlife Pharmaceuticals, CO, USA) using a CO2
powered dart projector (Pneu-dart, Williamsport, PA, USA).
For Movi detection in bighorn sheep, we fully inserted single polyurethane culture
swabs (BD CultureSwabTM EZ System) into both nares and slowly rotated the swab shaft
while gently contacting the mucosal tissue of the nasal wall and withdrawing the swab
with circular motions. Duplicate swabs were collected and stored at -20 C after
replacement in the sterile sheath prior to submission to the lab for polymerase chain
reaction (PCR) detection of Movi (Ziegler et al. 2014). We collected 8-10 ml of blood
via jugular venipuncture and extracted 0.5–1-ml serum for detection of antibodies to
Movi via competitive enzyme-linked immunosorbent assay (ELISA) performed by the
Washington Animal Disease Diagnostic Laboratory (WADDL). We shipped all samples
overnight to Dr. Thomas Besser’s laboratory at Washington State University (Pullman,
WA, USA) for PCR analyses and strain-typing using multi-locus sequence typing
(Cassirer et al. 2017). We collected the same samples at mortality and in addition, we
used bronchial swabs at necropsy to detect and strain-type Movi inhabiting the lower
respiratory tract.
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Clinical observations
We conducted 20-minute vehicle-based observations using binoculars at distances
of ≥ 27 m daily from 1 April 2015 to 1 April 2017. We recorded signs of respiratory
disease and ranked them from 0–10 to indicate the observed severity ranging from absent
to extremely severe. Signs recorded included lethargy, sternal recumbency, ear paresis,
nose licking, nasal discharge, and coughing for each individual (Appendix B). From the
first indication of pneumonia-related symptoms (i.e., presence of minor cough or clear
nasal discharge), we estimated each individual’s date of infection from a novel crossstrain transmission event as three-weeks prior to the onset of the initial symptom (Besser
et al. 2014; Appendix C). We classified an individual as asymptomatic/recovered if they
did not present any indication of coughing or nasal discharge for a minimum of 60 days.
To track disease progression during the cross-strain transmission event, we used daily
clinical scores for all adults from 16 July 2015–1 April 2017.
Environmental samples
To identify potential environmental factors contributing to transmission of Movi
across pens, we sampled air, water, flying insects, bird nests, and soil. We also collected
various opportunistic samples of bird nests and fly traps in pen shelters when possible.
We conducted aerosol sampling bi-weekly at each of ≥ 5 pens (Sartorius MD8 Airport
Portable Air Sampler, Fisher Scientific, Waltham, MA, USA) for 20-minutes at 3 defined
locations: immediately outside and down-wind of the enclosure being tested (<1 m from
pen fence), halfway between the enclosure being tested and the immediately adjacent
down-wind pen (halfway from source pen fence), and immediately outside the nearest
adjacent down-wind pen (15 – 30 m from source pen fence) of the pen being sampled. At
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the end of the air sampling period, we placed half of the air filter in 10-ml Hayflick’s
broth and placed the other half in a sterile storage bag. We collected weekly drinking
water samples from the 25-gal trough permanently placed in each pen. We collected 50ml of surface water and then thoroughly mixed the water and collected 50-ml from the
center of the water trough. We conducted invertebrate (e.g., Musca spp.) contamination
assessments using fly tape traps and collecting replicate swabs of the external surface of
trapped flying invertebrates. Finally, we tested observer-fomite transmission by securing
gauze to the bottom of work boots and traversing the pen for 5-minutes focusing on areas
sheep spent the most time (e.g., feed, water stations, shelters). All environmental
samples were sent to Dr. Thomas Besser’s laboratory for Movi culture and PCR
diagnostics.
Statistical Analyses
To capture the initial transmission and incubation prior to the epizootic, which
was first observed 15 July 2015, we initiated our model 1 January 2015 and concluded it
on 1 April 2017. To model the disease progression during the cross-strain transmission
event, we used a Bayesian mixture model for competing risks (Larson and Dinse 1985) to
estimate the daily probability and daily rate of transitioning to and from disease states and
to death. This approach assumed all individuals will transition from their current state to
a new state at some point in time (i.e., probability of staying in its current state as time →
∞ = 0), and the state to which an individual transitions to next was determined by some
stochastic mechanism when they entered their current state (Larson and Dinse 1985).
With this structure, individuals exhibited staggered entry into each new state because of
heterogeneity in transition times due to individual host response. We also assumed that
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an individual’s origin for the daily hazard rate of transitioning is the daily interval at
which they entered a state.
We modeled the overall probability an individual in state i transitions to state j,
and then, conditional on this transition, we estimated the associated daily hazard rate of
making the transition. Thus, the transition probabilities acted as mixing parameters for
the various hazard rates. Using Kermack and McKenrick’s (1927) classic compartmental
SIR model structure, we developed a model with three main individual disease states:
susceptible (S; i.e., susceptible to infection), infected (I; i.e., those that were currently
displaying clinical symptoms of respiratory disease and were presumed infectious), and
recovered (R; i.e., those who have had the disease but were no longer symptomatic;
Anderson and May 1991). We classified all adults as S at the start of our model (1
January 2015). Since we did not have real time information on disease status, we
classified individual disease state based on daily clinical symptoms of respiratory disease.
We used cough and nasal discharge scores to define disease states. We defined the start
of disease state I as 3 weeks prior to the date of the onset of cough (score ≥ 1) or nasal
discharge (score of > 2) (Besser et al. 2014, Appendix B). We classified an individual as
R if they did not present any indication of coughing or nasal discharge (score ≤ 2) during
daily clinical symptom observations for a minimum of 60 days.
The model was structured such that I individuals could not return to the S state;
however, R individuals could return to the I state. We also included two absorptive states
(i.e., probability of transitioning from an absorptive state = 0). The first was death
unassociated with disease (mortalityo), and individuals could die and enter this state from
any of the states. The second was disease-associated death (mortalityp). Only I
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individuals could enter this state. Lastly, individuals that did not die during the study we
considered to be right-censored in the state they occupied at the study’s conclusion. The
model structure is shown in Figure 2.
Transition Probabilities–We estimated most transition probabilities as a function
of covariates using a logit link function as follows:
𝑙ogit (pi,j ) =Xβ,
where 𝑝𝑖,𝑗 is the probability of transitioning from state i to j during the study, X is a
covariate matrix, which varied between transition probabilities, and β are the parameters
for the covariate effects. However, individuals transitioning from state I could move to 3
different potential states, and therefore, we used a multinomial logit model:

pI,j =

exp (Xβj )
1+ ∑2j=1 exp (Xβj )

,

where βj are the parameters for the covariates associated with transitioning to state j from
I.
Table 2 contains the covariates used for each transition probability. For the
probabilities of transitioning from S, (p2), we included an effect for the individual’s
immune response (Movi cELISA % inhibition value; %I hereafter) prior to cross-strain
infection as determined by clinical symptoms and subsequent results of PCR and Movi
strain type testing and the known-Movi exposure (initial strain) of that individual. For
the probabilities of transitioning from I, (p3, p4), we included effects for each individual’s
immune response prior to the cross-strain transmission event, the individual’s immune
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response during active cross-strain infection, and the individual’s initial Movi strain.
Lastly, we specified the probability of transitioning back to I from R (disease recurrence;
p6) as a function of the individual’s initial Movi strain at the start of the study.
Transition Hazard Rates–We used a piece-wise constant function to model each
daily transition hazard as a function of covariates of interest using a proportional hazards
assumption:
ln (λi,j,t ) = X φ + δt ,
where 𝜆𝑖,𝑗,𝑡 is the daily hazard of transitioning from state i to j during daily interval t, 𝜑
are the parameters for the covariate effects and 𝛿𝑡 is a regularizing term for daily interval
t, which is used to account for temporal autocorrelation and provide temporal smoothing.
It is worth noting that we used a constant model for 𝜆𝑖,𝑗,𝑡 where j is non-diseaseassociated death regardless of the current state i because this transition hazard rate was
independent of disease state.
The δt parameters were only used in modeling hazard rates, and we used a kernel
convolution model (Higdon 2002) to regularize across days of the study when
transitioning from S to I and from I to disease-associated death. The δt parameters were
held constant for all other transitions. This modeling approach provided a flexible means
of accounting for temporal autocorrelation and permits the estimation of the level of
smoothing supported by the data (Higdon 2002). For the S to I transition hazard with
knot locations set at each day of the study, the model was:
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N

δt = ∑
n=1

dist2t,n
exp ( 2 ) I [d ≤ 120] × αn ,
2σs
√2πσs
1

which uses a Normal density kernel truncated at 120 days (i.e., days beyond 120 days
from the t do not influence δt ) with a variance of σ2s , dist2t,n is the squared distance
between t and the nth knot location, and αn is the latent random day effect at the nth knot.
We specified a Gamma (1, 1) for

1
σ2s

, and a Normal (μ = 0, σ2α ) prior for the αn vector of
1

effects. We used a Gamma (1, 1) prior on the precision, σ2 . We also calculated the ratio
σ

of the standard deviations, σs , which provided an assessment of the amount of temporal
a

smoothing to random variation in the kernel convolution. A large ratio (<1) indicated the
δt effects will be smooth, whereas a small ratio indicated little smoothing and the process
behaved randomly. We used the same kernel convolution model for smoothing the
temporal effects, δt , for the I to disease-associated death transition and once again we
1

1

s

a

used a Gamma (1, 1) prior on σ2 and a Gamma (1,1) prior on σ2 .
Table 3 contains the covariates used in each hazard model. For the transition
hazard rate from S to I, (λ2), we included an effect of the individual’s immune response
prior to active cross-strain transmission, and distance from NV-400 strain pen on the log
hazard rate. To model the log hazard of transitioning from I to mortalityp, (λ3), we
included an effect of the individual’s known immune response prior to cross-strain Movi
infection, the individual’s immune response to active infection (i.e., Movi serological test
results averaged from of the time of entry into state I until mortality or the end of the
study). For the transition from I to the R state (λ4), we modeled the log hazard to include
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an effect of the individual’s initial immune response, the individual’s immune response
during the active cross-strain infection, and the individual’s known initial Movi strain.
Finally, we modeled the hazard of transitioning back to I from R (i.e., disease recurrence;
λ6) as a constant.
Posterior Distribution–Given these probabilities and hazards, the kth individual’s
transition from state i to j makes the following contribution to the log likelihood, 𝑙𝑙𝑖,𝑗,𝑘 :
ej,k

ri, k

lli,j,k = log (pi,j ) - ∑ λi,j,t + log (1- exp (- ∑ λi,j,t )) ,
t=ei,k

t=ri,k

where ei,k is the kth individual’s entry time into state i and ri,k is the last time the kth
individual was known to be in state i. Note, this model allows for interval censoring of
the transition time (i.e., the transition time is only known to have occurred between ej,k
and ri,k ). Individuals who are in a non-death state at the end of the study (i.e., right
censored) contribute the following:
J

T

lli,j,k = log (∑ pi,j × exp (- ∑ λi,j,t )) ,
j=1

t=ei,k

where the first summation is over the J possible states that can be transitioned to from
state i, and T is the day the study ended. To complete our model, we specified diffuse
Uniform (-100, 100) priors on the intercept/base-line log hazard rate, and Normal (μ = 0,
σ2 = 100) priors for all covariate parameters used in estimating the transition probabilities
and the daily hazard rates. The posterior distribution is then proportional to the sum of
the log of the prior distributions and the log likelihood.
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Estimation–We employed JAGS (Plummer 2003) in Program R (R Core Team
2018) via the R2JAGS package (Su and Yajima 2015) to estimate the posterior
distributions of our parameters of interest and used Markov Chain Monte Carlo (MCMC)
methods. Because our likelihood is in a non-standard format, we used the “zeros trick”
(Lunn et al. 2013) to permit its use in JAGS. We ran 3 chains for 100,000 repetitions,
and removed the first 25,000 iterations for burn-in. Each chain was started with
dispersed starting values, and graphical checks were used to monitor for evidence of nonconvergence.
Simulated population–To determine the potential population-level impacts of
individual host responses to a disease event like that experienced at the SDSU Captive
Wildlife Research Facility for a wild bighorn sheep herd, we used the posterior predictive
distributions for the parameters from the model estimated above to simulate a disease
event and its progression in a simulated bighorn sheep population. Specifically, we used
the last 75,000 posterior draws from our model for each parameter and estimated the
mean number of bighorn sheep, out of a simulated population of 150, that are in each
state over 720 days.
RESULTS
Outbreak
We established a captive facility containing 37 bighorn sheep originating from
seven wild populations with known previous exposures to specific Movi strains in 9 pens,
4 with Movi chronic carriers and 5 without (Fig. 1). Shortly after the first observed lamb
pneumonia cases in the pens containing chronic carrier ewes, we observed unexpected
adult respiratory disease in multiple pens including both pens with and without chronic
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Movi carriers, frequently associated with infection by Movi strains novel to the bighorn
sheep within the affected pens. This outbreak allowed us to investigate individual host
response to genetically diverse strains of Movi.
Timing of Lamb vs Adult Pneumonia–In 2015, lambs were born from 24 March –
21 June and all lambs died from pneumonia or other causes by early August (Appendix
C). The onset of clinical signs of lamb pneumonia preceded the detection of pneumonia
in adults and a cross-strain transmission event. Clinical signs of pneumonia began with
the Snowstorm lambs on 28 April 2015. The Snowstorm lamb mortality occurred in May
and June at 43 days of age (range = 22 – 87 days; n = 7) and all lambs had expired in that
pen (Pen 9; Fig. 1, Appendix C) by 28 June 2015. Comparatively, the onset of lamb
clinical pneumonia was later in other pens. In an adjacent pen (Pen 7; Fig. 1, Appendix
C) the first observation of clinical signs was 27 May 2015 and subsequent mean age at
mortality was 38 days (range = 27 – 49; n = 2). The final lamb in Pen 7 expired 14 July
2015, immediately prior to clinical detection of cross-strain infection in adults. However,
the NV-400 strain type detected in the mortality samples for both Pen 7 lambs was not
expected based on the carrier ewes present and represent the first PCR-confirmed
indication of cross-strain transmission (Appendix C).
Near the end of July 2015, we witnessed the unexpected mortality of two
Snowstorm ewes (Pen 9; Fig. 1). Cause of death was attributed to a severe acute
pneumonia and infection with strain NV-400. Simultaneously, we noticed adults, which
were previously asymptomatic, in an adjacent pen (Pen 7; HC-404; Fig. 1A) exhibiting
severe clinical indications of pneumonia immediately after the last lamb expired in that
pen. Adult mortalityp may have been attributed to a generally slow transmission between
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pens (Appendix C). Subsequent to the index case of clinical pneumonia attributed to
cross-strain infections in each pen, the median number of days for all adults in the pen to
display clinical disease was 15 days (range = 9 – 47 days). Median time between onset of
clinical symptoms and mortalityp was 126 days (range = 45 – 489 days).
Clinical observations summary– Observation of clinical symptoms of respiratory
disease was the basis of the morbidity and infection calculation used in our study. We
detected 21 instances of transmissions of the NV-400 strain to sheep previously exposed
to HC-404, BB-393/HC-404, and SD-398 and 4 transmissions of HC-404 to the sheep
previously exposed to BB-393/HC-404 and SD-398. After 1 November 2015, Movi
strains NV-400 and HC-404 were the only strains detected. We documented signs of
respiratory disease in 95% (n = 35) of study animals. The 95% morbidity rate
documented exceeds the proportion of individuals that were subsequently documented as
infected with a novel Movi strain (68%), indicating some bighorn sheep may have
become symptomatic when only their initial strain could be detected. Cross-strain
infections were detected from July – October 2015, and time to detection varied by pen
assignment but generally moved from east to west, opposite of the prevailing winds,
within the research facility (Appendix A). Specifically, 82% (n = 9) of individuals
entering the study with NV-400 (the Snowstorm bighorn sheep herd) showed clinical
signs when only their initial strain was detectable. Only 11% (n = 3) of individuals with
all other strains were clinically infected by their initial strain immediately prior to crossstrain infection detection.
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Health Sampling
Between February 2015 and December 2016 we collected 2 – 10 nasal swab
samples from the 37 bighorn sheep in our study (2: n = 1; 3: n = 5; 4: n = 6; 5: n = 1; 6: n
= 9; 7: n = 6; 8: n = 5; 9: n = 4; 10: n = 1) . The proportion of Movi-positive individuals
in health samples pooled monthly increased from 0.19 to 0.83 prior to and during the
observed respiratory disease epizootic, respectively. During our study, we confirmed
pneumonia as the cause of death in 43% (n = 16) of the captive bighorn sheep (Fig. 3).
Other sources of mortality (24%) were darting complications (n = 2), birthing
complications (n = 1), West Nile Virus (n = 1), liver hemorrhage (n = 1), fly strike (n =
1), gastric abscess (n = 1), and euthanasia due to emaciation (n = 1) and injury (n = 1;
Fig. 3). At the end of our study, survival was 33%, of which half (n = 6) remained in the
I state (Fig. 3).
Environmental Samples
After detection of cross-strain Movi infections, we initiated sampling to help
understand potential sources and routes of transmission. We detected Movi in air, water,
and invertebrate samples (Table 4). We identified aerosol Movi downwind of the target
sampled pen (directly outside of target pen: n = 9, between target pen and nearest
occupied pen downwind from target pen: n = 1, and outside nearest occupied pen
downwind from target pen: n = 1). We documented 9 indeterminate air samples (within
the occupied pen: n = 2, directly outside of target pen: n = 4, and between target pen and
nearest occupied pen downwind from target pen: n = 3).
We detected Movi in 22 water, 5 invertebrate, and 1 permanent fly trap samples.
We did not detect Movi on the soil surface or in a bird nest constructed in an occupied
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pen’s shelter (Table 4). Viable Movi, based on detection of Movi proliferation in broth
culture, were not detected in any environmental sample.
Statistical Analyses
Right Censored Susceptible Adults–One individual carrying HC-404 Movi (e.g.,
always positive by PCR; n = 8) failed to display clinical symptoms of pneumonia during
our study and was right censored in the S disease state. One other individual that was
right censored in the S disease state was a ewe from the Snowstorms that had lacked
clinical symptoms of pneumonia and was never documented with Movi carriage during
our study. All other adults in our study transitioned out of the S disease state.
Transition from the Susceptible State to the Infected State–Our model indicates bighorn
sheep are very susceptible to the introduction of a novel Movi strain into the herd.
Generally, our results indicate a high probability that a previously exposed bighorn sheep
will become clinically infected when exposed to a novel Movi strain (Fig. 4A). The
Movi strain type to which an individual was previously exposed did not affect the
probability of infection (Table 2). The initial immune response, defined as the %I value
at the nearest sampling event (4–7 months) for that individual prior to the 2015
pneumonia epizootic; %II hereafter), had raw values ranging from 4.25–89.94%. Effect
size for median effect of probabilities and daily hazards within are presented on the logit
and log scale, respectively. There was a significant effect of %I on the probability of
becoming infected (median effect size = -10.14; 95% CI = -21.79 – -1.40), with
individuals with higher pre-existing %II values being less likely to become infected with
a novel strain. The probability of being infected was 1.0 for individuals with %II values
less than 50%, the cutoff for a positive result for the Movi cELISA. The probability of
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being infected was nearly 1.0 for individuals with a Movi %II value of 62% inhibition
prior to the pneumonia outbreak and decreased to 0.5 or less for individuals with %II
values of 80% or higher (Fig 5).
The rate at which individual bighorn sheep became infected, defined as the
infection hazard, was not constant but rather exhibited a bimodal distribution over time.
Most individuals exhibited disease onset around study day 200 (late July 2015) or 275
(early October 2015 (λ2; Fig. 6A). An individual’s %II value did not affect their infection
hazard (λ2; median effect size = -0.09; 95% CI = -0.45–0.32; Table 3). Proximity to the
NV-400 pen (median effect size = -0.31; 95% CI = -0.74 – 0.04) had a marginal effect on
the infection hazard, with individuals penned closer to the NV-400 pen becoming
infected sooner than individuals penned farther away; however, this was confounded with
previous strain exposures since bighorn sheep with the same exposures were penned
together (Fig. 1). The ratio of the standard deviation for infection hazard (median effect
size = 0.71; 95% CI = 0.34–2.03) in the kernel convolution indicated the process exhibits
more random behavior than a strongly correlated temporal process.
Transition from the Infected State to the Mortalityp State–Our model presents a
large degree of uncertainty when estimating the long-term probability of bighorn sheep
transitioning out of the infected state (Fig. 5b). From the infected state, one transition is
to the mortalityp state (Fig. 2). The covariate effects of %II and previous Movi strain type
exposure, as well as the indicator variable for NV-400-specific cross-strain transmission
(CST NV-400) did not have a significant effect on the probability of an infected bighorn
experiencing mortalityp (Table 2). However, individuals with higher active immune
responses (the mean of %I values from the onset of active infection until recovery, if

22
applicable, or mortality; %IA hereafter) during the epizootic were significantly more
likely to experience mortalityp (median effect size = 3.21; 95% CI = 0.57 – 7.39). The
probability of mortalityp for individuals with %IA less than 50% was 0. The probability
of mortalityp rose above 0 for %IA above 60% and increased above 0.35 for individuals
with %IA above 80% (Fig. 7).
Daily hazard of mortalityp was consistent with most mortality events occurring by
day 300 of our study (λ3; Fig. 6B). Mortalityp hazard was not associated with %II
(median effect size = -0.13; 95% CI = -0.81– 0.84). In contrast, there was an effect for
%IA (median effect size = 1.10; 95% CI = 0.18 – 2.23) on mortalityp hazard, with
individuals with a larger %IA experiencing mortalityp faster than individuals with a lower
%IA (Table 3). The ratio of the standard deviation for mortalityp hazard (median effect
size = 1.17; 95% CI = 0.35–7.12) in the kernel convolution indicated that there was
evidence that this hazard exhibited evidence of being a temporally correlated process.
Transition from the Infected State to the Recovered State–Our model predicts the
probability that an individual remains in the infected state is relatively high (> 0.5) up to
100 days post-infection; however, our model reflects a greater degree of uncertainly
thereafter (Fig. 4C), which may be due to a small sample size (n = 8). Probability of
recovery was not attributed to %II (Table 2), and individuals experiencing cross-strain
infection by NV-400 were marginally less likely to recover (median effect size = -7.08;
95% CI = -18.04–0.50). In addition, bighorn sheep with a larger %IA were less likely to
recover from novel Movi strain infection (median = -2.31; 95% CI = -5.52 – -0.05).
Finally, bighorn sheep that had previous or current exposure to the HC-404 strain were
more likely to recover to an asymptomatic state following infection by the Movi NV-400
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strain (HC-404: median effect size = 5.29; 95% CI = 0.42 – 12.66; BB-393/HC-404:
median effect size = 6.44; 95% CI = 1.21 – 14.51; (Table 2).
The effect of immune response may drive recovery hazards (λ4), but with varying
influences. If an individual were to recover, recovery occurred faster for bighorn sheep
with increased prior immunity (%II; median effect size = 1.15; 95% CI = 0.10 – 2.43) but
slower for bighorn sheep experiencing a higher immune response during the active crossstrain infection (%IA; median effect size = -1.11; 95% CI = -2.28 – -0.20; Table 3).
Transition from the Recovered State to the Disease Recurrence State–Very few
individuals experienced disease recurrence in our study (n = 3). Although our sample size
is small, our model does not suggest differences in the probability of clinical disease
recurrence based on initial Movi strain exposure histories (p6; Table 2).
Simulated Population–Our simulated bighorn sheep population model assumed all
bighorn sheep are susceptible to epizootic pneumonia and that clinical disease may occur
rapidly (Fig. 8). A small number of bighorn sheep immediately became infected but
there was a 4.5-fold increase in number of infected individuals between 120 and 300
days, which then slightly decreased, resulting in 50% of all surviving bighorn sheep in
the population remaining infected for the duration of the simulation. Bighorn sheep
began to experience pneumonia-related mortality at the 200th simulated day and mortality
slowly increased until approximately 1/3 of the population had succumbed to respiratory
disease. Very few (approximately 25%) bighorn sheep recovered from the infection with
the novel strain of Movi, and approximately 10% of the simulated population died due to
non-pneumonia causes over the course of 720 days (Fig. 8).
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DISCUSSION
This is the first study to examine individual host response to a Movi strains using
intensively sampled bighorn sheep with known exposure histories. We found that adult
bighorn sheep are highly (95%) susceptible to a novel Movi strain regardless of previous
exposure history. However, strains to which an individual was previously exposed may
influence the outcome following infection: either mortality or recovery. We described
ongoing carriage of a pathogenic strain (NV-400) that caused high adult mortality (45%)
of individuals that were previously infected with it. Further, for the individuals that
contracted this pathogenic strain without prior exposure, we describe high (92%)
mortality rates attributed to pneumonia. Waning and boosting immunity prior to and
during outbreaks, respectively, may drive observed heterogeneities in observed adult
bighorn sheep disease outcomes. Our study also documents indirect transmission up to
30 m from infected bighorn sheep, which we hypothesized resulted from aerosolized
Movi from symptomatic infected bighorn sheep in adjacent pens.
Strain Type and Competition
Our study is the first to report multiple cross-strain Movi exposures and
subsequent disease response from intensively monitored captive bighorn sheep. Our
findings support similar conclusions from previous work that suggest that Movi strains
vary in pathogenicity and that previous strain exposure does not induce immunity to
novel strains (Felts et al. 2016, Justice-Allen et al. 2016, Cassirer et al. 2017). Some
investigators have reported that Movi infections in domestic hosts can result in more
severe pneumonia when multiple strains are present (Parham et al. 2006, Rifatbegović et
al. 2011). The MLST strain typing method characterizes approximately 0.15% of the
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genome (Cassirer et al. 2017). Our strain typing method was not able to detect coinfection unless both strains are at similar concentrations in the sample and are amplified
for sequencing at similar efficiency. The MLST strain-typing method used in our study,
however, has been widely applied in epidemiologic and evolutionary studies. Kamath et
al. (2019) validated the strengths of employing this method to describe Movi strain
diversity and bighorn sheep spillover events from 1984–2017 throughout the western
United States. The likelihood and effect of multiple simultaneous Movi strain infections
in bighorn sheep pneumonia is unknown and warrants investigation. In addition, it is
plausible that biologically different strains are included within a single MLST strain type.
The MLST strain type procedures used in our study indicate all the NV-400
strains are relatively closely related phylogenetically but provides no information about
variation in presence or expression of specific virulence genes. Interestingly, we did not
detect a cross-strain infection in the Snowstorm herd although they were in close
proximity to and downwind of the prevailing wind direction to the pens with other strain
types (Fig. 1). However, in < 2 years, the Snowstorm bighorn sheep experienced 45%
adult mortality due to pneumonia. Our findings contrast with observations of relatively
low levels of adult sporadic mortality following initial exposure (over a period of ≥ 4
years, approximately 20-25% of adults experienced fatal pneumonia; Smith et al. 2015).
A possible explanation for the paradoxical observations regarding NV-400 is that the
genotyping method used to identify Movi strains in this study fails to distinguish multiple
within-strain variants that may vary in virulence and/or neutralizing surface epitopes.
Not only did the NV-400 strain usually appear to dominate other strain types once
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contracted by the host, but 81% (n = 15) of bighorn sheep that died due to pneumonia
during our study were attributed to NV-400 infections by MLST genotyping.
Immune Response
Several findings of this study suggest that adaptive immunity is an important
factor driving individual heterogeneity in the response of bighorn sheep to disease.
Immune responses (antibody scores) present prior to the outbreak were associated with
resistance to outbreak-associated disease, and, if recovery occurred, a faster rate of
recovery. However, higher immune responses (antibody scores) during outbreakassociated disease were associated with both increased probability and hazard of
pneumonia-induced mortality, and if recovery occurred, with a slower rate of recovery
(Table 2).
Generally, immunity is developed during infection of a host, and acts to reduce
pathogen establishment, survival, reproduction, and/or maturation (Wilson et al. 2002).
However, immune responses may also be non-protective, ranging from benign nonneutralizing responses that simply serve as a marker of antigenic exposures associated
with infection to immunopathological responses associated with adverse reactions and
increased disease severity (Simenka et al. 1993). A stronger serum antibody response
was associated with more severe disease individual hosts (Rattus spp., Mus spp.)
experimentally infected with Mycoplasma pulmonis. Further, adaptive immunity did not
affect recovery of these hosts from chronic mycoplasma infection and disease (Simenka
et al. 1989, Cartner et al. 1995).
Our measure of immune response to Movi is a cELISA test, which detects
antibodies based on their ability to inhibit binding of a Movi-specific monoclonal
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antibody to Movi antigen in vitro. The monoclonal antibody used in the assay was
selected on the basis of immunodominance of its epitope across multiple bighorn sheep
populations infected by diverse Movi strains, but this epitope has not been shown to be
involved in protective immunity. As a result, immune responses as measured by percent
inhibition (%I) should be considered to primarily reflect the intensity of current or past
Movi exposure. Therefore, increased %I may be expected in individual animals unable
to mount an effective immune response, and consequently are subjected to a higher or
more sustained pathogen load. Both beneficial and adverse effects of immune responses
to Movi infection are plausible: while immune responses may be associated with
decreased pathogen carriage (Niang et al. 1998, Plowright et al. 2013), strong humoral
immune responses may induce autoimmune responses in domestic sheep and have been
hypothesized in wild sheep (Niang et al. 1998, Cassirer et al. 2018). Cassirer et al.
(2017) documented adult bighorn sheep that died following cross-strain transmission had
higher Movi %I prior to the novel strain invasion compared to those that survived
disease. Although our study does not support this finding, our study does indicate that a
potential immune “over-reaction” during, rather than prior to, a novel infection may be an
important factor driving pneumonia-induced adult bighorn sheep mortality.
While most individual bighorn sheep that survive infection clear Movi carriage,
others survive but fail to clear and become chronic carriers that serve as a reservoir to
sustain the pathogen in the population, despite high immune responses (Cassirer et al.
2018). Other Mycoplasma pathogens also are documented to have the ability to persist in
the face of dramatic immune responses (Simenka 2005). Lacking a better understanding
of the interactions between the host’s immune system and Movi virulence factors, the
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cELISA may fail to distinguish protective from ineffective or harmful immune responses,
making it difficult to interpret its effects when evaluating bighorn sheep management and
recovery from a pneumonia epizootic.
It is generally accepted that immune responses are genotype-specific, with
previously unseen genotypes having a growth advantage in semi-immune hosts (Simenka
2005). Our study reflects this complex notion in which individual bighorn sheep that had
stronger immune responses following previous Movi exposure were less likely to exhibit
disease symptoms (Table 2), and experienced shorter recovery times (Table 3). The
majority (67%; n = 6) of bighorn sheep that recovered, however, were challenged by their
initial strain or a strain that they had previously been exposed to in the wild (NV-400 or
BB-393/HC-404, respectively). In contrast, only 13% (n = 3) of bighorn sheep that
experienced a novel cross-strain transmission event recovered in our study.
Simulated Population
In Hells Canyon (Idaho, Washington, and Oregon, USA), a minimum of 34
pneumonia events occurred in these interconnected populations over a 14-year period,
including invasion episodes that resulted in high all-age mortality followed by recurring
epizootics mostly in juveniles (Plowright et al. 2013). Post-invasion dynamics were
characterized by sporadic adult mortality and variable but usually high mortality in
lambs. Mortality events following Movi invasion ranging from 30–50% are common
(Jorgenson et al. 1997, Cassirer et al. 2013, Plowright et al. 2013). The fates of
individuals in our study (Fig. 4) and simulated models (Fig. 8) agree with these previous
conclusions.
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The simulated population model reported here was developed to offer insight
regarding potential effects of a novel Movi strain introduction in a previously exposed
wild herd if the herd responded similarly as our captive bighorn sheep. Our simulated
model suggests approximately one-half of the population will remain symptomatic for 2
years following introduction of a novel strain (Fig. 8). This contradicts many
observations following natural infections (e.g., Yakima Canyon where 97% (n = 34)
recovered within 2 years; Bernatowicz et al. 2016); however, it is unclear if any
individuals remained symptomatic. Healthy periods (years) typically occur in exposed
free-ranging populations (Cassirer et al. 2013, Plowright et al. 2017). Bighorn sheep
disease response and expression are complex and, in part, may be explained by
differences among Movi strain types, other secondary infections, and non-infectionrelated factors (e.g., sinus tumors; Fox et al. 2015). Social behaviors that would regulate
frequency-dependent transmission following recovery could facilitate protection of some
groups following disease outbreaks (Manlove et al. 2014) and may be an important
mechanism driving recovery of bighorn sheep.
In free-ranging populations, state transitions may differ than presented in our
conclusions as host contact patterns and dose associated from contacts are likely to be
driving factors attributed to heterogeneity in disease response. The stochasticity of
disease occurrence rates presented here are likely due to the initial infection in most pens
occurred via indirect transmissions (i.e., one individual becoming infected in a pen)
followed by direct contact with that newly highly infectious individual (i.e., pathogen
transmission throughout the pen; [Fig. 6A]). Pens closest to the Snowstorm bighorn
sheep became infected and experienced mortality before the more distant pens in our
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study. In general, once one individual expressed clinical symptoms of novel strain
infection, the remainder of the individuals in the pen quickly followed (Appendix C).
The rapid spread and exposure of nearly all individuals in novel Movi invasion events has
previously been reported (Cassirer et al. 2017). Recovery from disease invasion may be
slow (Fig. 8) but persistent carriage could last ≥ 3 years (Plowright et al. 2017).
Environmental Factors
We detected Movi in aerosol, fly, and water samples although we were unable to
culture viable organisms from these samples. This is likely due, at least in part, to the
fastidious nature and rapid death of Movi outside of the mammalian host. A future study
that immediately inoculates aerosolized droplets into culture broth is needed. In spite of
careful planning and consideration of prevailing winds, we believe the most likely
mechanism of cross-strain transmission experienced during our study is Movi on
aerosolized droplets. Besser et al. (2014) reported Movi transmission to all yearling
captive bighorn sheep by a single source within and between pens up to 12 m distant.
Although average wind direction was generally opposite to pen-to-pen transmissions
(Appendix C), wind direction frequently varied and wind speeds of > 60 km/h were
common; wind gusts >100 km/h that occurred in late June and early August may have
facilitated rapid movement of droplets containing viable bacteria across the facility
(Appendix D). We detected aerosolized Movi DNA at the boundary of the nearest
downwind pen at the maximum range tested (30 m) from infected bighorn sheep.
Closely related Mycoplasma spp. infectious agents have been recognized as viable
and transmissible through aerosolization. M. hyopneumoniae, which causes atypical
pneumoniae in swine (Stärk et al. 1998, Desrosiers 2011), has been documented to be
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transmissible via aerosol droplets 9.2 km from the infected source pen (Otake et al.
2010). In addition, M. bovis, the primary agent in cattle pneumonia epizootics, and M.
synoviae and M. gallisepticum, which cause acute or chronic respiratory disease in
poultry, respectively, can infect livestock by airborne pathogen transmissions (Landman
et al. 2010, Kanci et al. 2017). Furthermore, secondary Pasteurellaceae agents are
transmissible through aersolization up to 18 m (Dixon et al. 2002) as well as by fomite
contamination (Burriel 1997, Clifford et al. 2009).
Our study is the first to document flies (Musca spp.) as a possible vector of
transmission for Movi in bighorn sheep infections. Some fly species feed on nasal and
oral discharge and have been implicated in the rapid spread of similar agents, including
M. conjunctivae, which causes infectious keratoconjunctivitis in wild and domestic
Caprinae (Degiorgis et al. 1999, Giacometti et al. 2002, Fernandez Aguilar et al. 2019).
Permanent fly traps were secured to the roof of shelters where symptomatic bighorn
sheep spent a considerable amount of time, particularly as disease progressed. The
positive Movi detection of the permanent fly trap could be the result of airborne particles
expelled during coughing. However, the Movi-positive fly tape was a direct sample of
flies and offers strong evidence as a possible route of transmission in captive studies.
Furthermore, the strain-type that was identified directly from flies (SD-398) had never
been detected in bighorn sheep carriage in that pen (Pen 1). Additional investigations
aimed at detecting transmissible and viable Movi from flies that feed on oronasal
secretions are necessary to better understand the effect of vector-borne Movi transmission
in bighorn sheep epizootics.
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Other Possible Sources of Contamination
Similar to other studies, under established biosecurity protocols, personnel who
were in daily contact with infected bighorn sheep were not a likely mechanism of Movi
cross-strain transmissions (Goodwin 1985, Batista et al. 2004). Anthropogenic (e.g.,
clothing) and other fomites (e.g., feed buckets) may serve as pathogen carriers that could
result in Movi contamination and merit consideration. We most often detected Movi in
water samples (Table 4) and observed various avian species (e.g., Sturnus vulgaris)
frequenting these established sites. Due to the failure to detect Movi in a frequently
visited nest within an infected pen, we assume that it is unlikely that birds following
contact with contaminated water present a risk of Movi transmission. We caution
investigators that Movi transmission or contamination may be possible via shared
contaminated water, especially in captive studies, but further investigation is
recommended.
Study Limitations
We did not intend to evaluate novel Movi strain invasions of bighorn sheep. As
such, the experimental design for our original study objective limited our individual
disease measurements to clinical observations for much of our study. However, when
capture and direct pathogen testing allowed, our disease state classifications based on
clinical observations concurred with 94% of all PCR and serological analyses. Further,
we assumed a model start date of 1 January 2015 was appropriate to capture “preoutbreak” disease dynamics (e.g., disease state S in our model). Although clinical
observations were conducted daily immediately upon arrival at our captive facility, we
did not record intensive daily individual adult disease symptoms until 15 July 2015.
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Adult general health notes were frequently documented prior to the index case of adult
disease on 15 July 2015. Therefore, we may have misclassified the true date of becoming
infected, particularly for the two Snowstorm adults that experienced pneumonia-induced
mortalityp in late July 2015. Further, as described above, a lack of detection does not
completely rule out that a given strain was not actually present. Lastly, the covariates
used to explain contribution to disease processes for a dose effect (e.g., distance to Pen 9
[Snowstorm bighorn sheep]; Fig. 1) and strain histories are confounded and the
unexpected mortality in Pen 9 suggests that dose may contribute to disease severity. A
better understanding is needed of how dose and exposure history influence response to
infection.
MANAGEMENT IMPLICATIONS
Bighorn sheep are extremely susceptible to Movi infection, and direct contact
does not appear to be necessary for transmission when animals are symptomatic, which is
an important consideration for captive and free-ranging bighorn sheep research and
management. Cross-strain infections may produce similar morbidity and mortality
patterns as the initial invasion of Movi into naïve bighorn sheep populations.
Understanding Movi exposure histories and minimizing exposure to new strains is critical
to successful management strategies. Further, some strains of Movi appear to cause more
disease than others. Studies that explore the interactions between the immune system and
Movi virulence factors may provide important insights for understanding heterogeneity in
bighorn sheep responses to infection.
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Table 1. South Dakota State University captive bighorn sheep source herds, Mycoplasma
ovipneumoniae genotypes (strain) detected in those herds, and number of adult bighorn
sheep used in our study.

Source Herd
Hells Canyon
Asotin
Lostine
Sheep Mountain
Black Butte
South Dakota
Rapid Creek
Badlands
Nevada
Snowstorm

Movi Strain

Strain Abbreviation

n

404
404
404
393/404 exposed

HC-404
HC-404
HC-404
BB-393/HC-404

9
4
2
8

398
398

SD-398
SD-398

1
2

400

NV-400

11
TOTAL

37
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Table 2. Estimated posterior distribution of disease state transition probabilities (pn) as a
function of covariates using a logit link function for state transitions susceptible to
infected (S-I) and disease recurrence (R-I) and a multinomial logit model for individuals
transitioning from the infected state: infected to pneumonia-related mortality (IMortalityp) and infected to recovered (I-R). Median effect of disease state transitions are
presented on the logit scale, and 95% lower credible limit (LCL) and upper credible limit
(UCL) are presented.
State Transition
S-I (p2)

I-Mortalityp (p3)

Predictor

Median

95% LCL

95% UCL

9.44

2.47

25.00

-10.14

-21.79

-1.40

8.09
1.02
8.84

-5.36
-12.93
-5.08

23.18
10.71
23.94

Intercept
%II

-2.03

8.76

-14.35

-0.40

-2.95

1.53

%IAƗƗ

3.21
3.76

0.57
-6.94

7.39
16.05

0.32
-1.71
6.29

-3.69
-6.07
-3.27

4.61
2.34
22.3

Intercept
%II

2.32

-7.01

13.40

1.48

-1.31

4.66

%IA
CST NV-400
Initial Strain
NV-400
HC-404
BB-393/HC-404
SD-398

-2.31
-7.08

-5.52
-18.44

-0.05
0.50

5.29
6.44
-1.59

0.42
1.21
-20.16

12.66
14.51
14.14

Intercept
%IIƗ
Initial Strain
NV-400
HC-404
BB-393/HC-404
SD-398

NV-400ƗƗƗ

CST
Initial Strain
NV-400
HC-404
BB-393/HC-404
SD-398
I-R (p4)

Significant
*

*

*

*
*
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R-I (p6)

Ɨ

Intercept
Initial Strain
NV-400
HC-404
BB-393/HC-404
SD-398

5.32

-0.04

16.14

0
-5.49
0

0
-16.33
0

0
0.27
0

indicates initial percent inhibition values per individual, defined as the quantification of Movi antibody

titers prior to cross-strain transmissions (disease state S (Susceptible), prior to 15 March 2015), used to
evaluate immune response to epizootic pneumonia.
ƗƗ

indicates average percent inhibition values per individual, defined as the quantification of an individual’s

immune response to active Movi infection, from the onset of active cross-strain infection (earliest 15 March
2015) until the remainder of the study.
ƗƗƗ

indicates confirmed indicator variable due to cross-strain transmission with NV-400 by multi-locus

sequence typing to characterize strains using partial DNA sequences of the 16S-23S intergenic spacer
region.
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Table 3. Estimated posterior distribution of daily disease state transition hazard (λn) as a
function of the covariates of interest using a piece-wise constant function. State
transitions presented are susceptible to infected (S-I), infected to pneumonia-related
mortality (I-Mortalityp), and infected to recovered (I-R). Hazard rates are presented on
the log scale, and 95% lower credible limit (LCL) and upper credible limit (UCL) are
given.

Median
-0.09
-0.31
-0.13

95% LCL

95% UCL

-0.45
-0.74
-0.81

0.32
0.04
0.84

%IAƗƗƗ

1.10

0.18

2.23

*

%II

1.15

0.10

2.43

*

%IA

-1.11

-2.28

-0.20

*

-

-

-

0.00
1.46
0.00

0.00
-1.00
0.00

0.00
4.91
0.00

State Transition

Covariate

S-I (λ2)

%IIƗ
DistanceƗƗ

I-Mortalityp (λ3)

%II

I-R (λ4)

Significant

Initial Strain
NV-400
HC-404
BB-393/HC-404
SD-398

Ɨ

indicates initial percent inhibition values per individual, defined as the quantification of Movi antibody

titers prior to cross-strain transmissions (disease state S (Susceptible), prior to 15 March 2015), used to
evaluate immune response to epizootic pneumonia.
ƗƗ

measure of proximity (m) of assigned pens (Pens 1 – 8) to the NV400 Pen, Pen 9 (Fig. 2).

ƗƗƗ

indicates average percent inhibition values per individual, defined as the quantification of an individual’s

immune response to active Movi infection, from the onset of active cross-strain infection (earliest 15 March
2015) until the remainder of the study.
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Table 4. Mycoplasma ovipneumoniae prevalence in environmental samples used to
identify possible modes of cross pen transmission in our study.

Sample
Air
Water
Fly tape
Fly trap
Avian nest
Boots

n
191
167
66
2
2
2

Movi P
0.08
0.13
0.02
0.50
0.00
0.00

Movi I
0.05
0.01
0.09
0.00
0.00
0.00

Movi N
0.87
0.86
0.89
0.50
1.00
1.00

where:
Movi P indicates proportion of positive detection of Movi in samples during PCR analysis
(CT ≤ 35.0); range = 29.4–35.0.
Movi I indicates proportion of indeterminate detection of Movi in samples during PCR
analysis (CT = 35.01-39.9); range = 35.4 – 37.3.
Movi N indicates proportion negative detection of Movi in samples during PCR analysis (CT
= 40).
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Figure 1. Captive bighorn sheep research facility design and pen assignments based on
known-Mycoplasma ovipneumoniae history and current carriage as of 1 January 2015
(A). Unintentional indirect novel Mycoplasma ovipneumoniae strain infections as of 1
January 2016 (B). Strain types listed as 404 is HC-404, 400 is NV-400, 398 is SD-398,
and 393 is BB-393/HC-404. A (+) indicates Movi detected in pen and (-) indicates Movi
not detected in pen. Shaded pens indicate pneumonia-induced mortality occurred in that
pen.
A.
Pen1
393
(-)

Pen 2
404
(-)

Pen 5
393
(-)

Pen 6
398
(+)

Pen 7
404
(+)

Pen 3
404
(-)

Pen 4
398
(-)

Pen 1
404
(+)

Pen 2
400
(+)

Pen 8
404
(+)

Pen 9
400
(+)

B.

Pen 4
404
(+)

Pen 3
404
(+)
0

30 m

Pen 5
400
(+)

Pen 6
400
(+)

Pen 7
400
(+)
Pen 8
400
(+)

Pen 9
400
(+)
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Figure 2. Reversable epidemiological SIR model of pneumonia in bighorn sheep.

p3, λ3

Susceptible

p2, λ2

Mortalityp

p4, λ4
Infected

Recovered

p6, λ6
p7, λ7
p5, λ5
p1, λ1

Mortalityo

where:
p1, λ1 = probability, hazardƗ, respectively, of non-pneumonia-related (other) mortality of susceptible individuals
p2, λ2 = probability, hazard of being infected (explicitly defined as displaying clinical symptoms of respiratory disease)
p3, λ3 = probability, hazard of pneumonia-related mortality
p4, λ4 = probability, hazard of recovery
p5, λ5 = probability, hazard of non-pneumonia-related (other) mortality of infected individuals
p6, λ6 = probability, hazard of disease recurrence
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p7, λ7 = probability, hazard non-pneumonia-related (other) mortality of recovered individuals
Ɨ Hazard

is defined as the daily rate at which individual bighorn sheep transition from one disease state to another.
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Figure 3. Fate of 37 adult captive bighorn sheep during our study. For individuals that
died, Mycoplasma ovipneumoniae (Movi) detection at mortality is reported. Mortalityp
indicates instances of pneumonia-related mortality. Mortalityo indicates instances of nonpneumonia-related (other) mortality. For individuals that survived during our study,
Movi detection ≥ 1 year following the pneumonia outbreak is reported.
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Figure 4. Results of a multi-state mixture model of competing risks estimating the
probability an individual remains in the following states during a novel cross-strain
Mycoplasma ovipneumoniae infection: (A) susceptible, (B) infected; and (C) recovered
population.

A.
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Figure 5. Covariate effect of initial Movi percent inhibition(%II) prior to the cross-strain
transmission outbreak on the probability of individual bighorn sheep becoming infected
with Movi (p2). Raw %II values were standardized by subtracting the mean (𝑥̅ = 62.12%)
and dividing by the standard deviation (SD = 25.60%) of %II values for each individual.
The raw Movi %II value range = 4.72–89.94%.
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Figure 6. Predicted posterior distributions on the log scale of daily state transition hazards
of (A) being infected by pneumonia and (B) pneumonia-related mortality before, during,
and after a pneumonia outbreak associated with cross-strain transmission of M.
ovipneumoniae.

A.
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Figure 7. Covariate effect of the mean active Movi percent inhibition (%I) during the
cross-strain transmission (%IA) on the probability of individual bighorn sheep dying of
Movi-induced respiratory disease (e.g., Mortalityp; p3). Raw %IA values were
standardized by subtracting the mean and dividing by the standard deviation of %IA
values for each individual. Mean Movi %IA is 76.47% (SD = 11.21%; range = 42.08–
87.93%).
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Figure 8. Predicted disease progression in a simulated wild bighorn sheep population (n =
150) using the posterior predictive distributions for the parameters describing the crossstrain transmission event in the captive bighorn sheep study (A). We assume the index
case of cross-strain infection initiates the disease simulation on Day 1. Total simulated
population size is presented over the course of the epizootic for a simulated wild bighorn
sheep population (B).
A.
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APPENDIX A. BIGHORN SHEEP SOURCE HERDS
Wild bighorn sheep source herds selected for translocation to the South Dakota State
University Captive Wildlife Research Facility, Brookings, South Dakota.
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APPENDIX B. DAILY CLINICAL SYMPTOMS SCORING

Adult Respiratory Disease Scoring Sheet
Dam #

Sire #

DOB
Sex: (Circle)

Male

Female

Pen #:

(Circle): Carrier

Negative

VISUAL ASSESSMENTS:
1. Inappetence
2. Lethargy
3. Cough
4. Nasal Discharge
Date

1

2

3

4

5

6

Intermittent

Unknown

5. Droopy Ears
6. Nose Licking
7. Weakness/Recumbancy
8. Head Shaking
7

8

Score

Scorer

Notes
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APPENDIX C. PNEUMONIA OUTBREAK DETAILS
Pen assignments, onset of clinical symptoms, and fates of captive bighorn sheep adults
relative to lambs experiencing endemic pneumonia in 2014 and the pneumonia outbreak
attributed to cross-strain Movi infections in 2015 (all-age mortality). Known cause of
mortality includes pneumonia-induced mortality (Mortalityp) or other, non-pneumoniainduced mortality (Mortalityo). Endemic Movi strains are provided and identified with
pen numbers. Chronic carrier adults are identified with a “C” within individual figures
below. Gray figures indicate failure to detect a novel Movi strain within the specified
year (i.e., endemic Movi strain caused Mortalityp), and the black figures indicate the
detection of a novel Movi strain at least once within the year (i.e., cross-strain infection)
for adults and lambs in our study.
2014
Pen 1: HC-404
Affected: NA
Died: NA
Cause: NA
Strain: NA

Born: 5/11/14
Affected: NA
Died: NA
Cause: NA
Strain: NA

Affected: NA
Died: NA
Cause: NA
Strain: NA

Born: 5/12/14
Affected: NA
Died: NA
Cause: NA
Strain: NA

Affected: NA
Died: NA
Cause: NA
Strain: NA

Born: 5/21/14
Affected: NA
Died: NA
Cause: NA
Strain: NA
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Pen 7: HC-404
Born: 5/3/14
Affected: 6/3/14
Died: 7/4/14
Cause: Mortalityp
Strain: HC-404

Affected: NA
Died: NA
Cause: NA
Strain: NA
Affected: NA
Died: NA
Cause: NA
Strain: NA
Affected: NA
Died: NA
Cause: NA
Strain: NA

C

C

Born: 5/19/14
Affected: 5/29/14
Died: 6/30/14
Cause: Mortalityp
Strain: HC-404

2015
Pen 1: BB-393/HC-404 Exposed
Affected: 8/13/15
Died: NA
Cause: NA
Strain: HC-404

Born: 5/21/15
Affected: 7/22/15
Died: 9/5/15
Cause: Mortalityp
Strain: HC-404

Affected: 7/16/15
Died: NA
Cause: NA
Strain: HC-404

Born: 6/1/15
Affected: NA
Died: 7/22/15
Cause: Mortalityo
Strain: NA

Affected: 7/15/15
Died: NA
Cause: NA
Strain: HC-404

Born: 6/3/15
Affected: 6/28/15
Died: 7/22/15
Cause: Mortalityp
Strain: HC-404

Affected: 8/2/15
Died: NA
Cause: NA
Strain: HC-404

Born: 6/21/15
Affected: NA
Died: 7/11/15
Cause: Mortalityo
Strain: NA
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Pen 2: HC-404
Affected: 8/17/15
Died: NA
Cause: NA
Strain: NV-400
Affected: NA
Died: 8/5/15
Cause: Mortalityo
Strain: NA

Pen 3: HC-404
Affected: 7/29/15
Died: NA
Cause: NA
Strain: HC-404

Born: 5/6/15
Affected: 6/8/15
Died: NA
Cause: NA
Strain: HC-404

Affected: NA
Died: NA
Cause: NA
Strain: HC-404

Born: 5/10/15
Affected: 6/14/15
Died: 8/25/15
Cause: Mortalityp
Strain: HC-404

C

Born: 5/19/15
Affected: 6/12/15
Died: 8/3/15
Cause: Mortalityp
Strain: HC-404

Affected: 9/3/15
Died: NA
Cause: NA
Strain: NV-400

Pen 4: SD-398
Affected: 8/17/15
Died: NA
Cause: NA
Strain: HC-404

C
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Pen 5: BB-393/HC-404 Exposed
Affected: 11/12/15
Died: NA
Cause: NA
Strain: NV-400

C

Born: 5/25/15
Affected: NA
Died: 5/28/15
Cause: Mortalityo
Strain: NA

Affected: 8/18/15
Died: NA
Cause: NA
Strain: NV-400

Born: 5/29/15
Affected: NA
Died: NA
Cause: NA
Strain: NA

Affected: 9/14/15
Died: NA
Cause: NA
Strain: NV-400

Born: 5/29/15
Affected: NA
Died: 9/8/15
Cause: Mortalityo
Strain: NA

Pen 6: SD-398
Affected: 8/18/15
Died: NA
Cause: NA
Strain: NV-400
Affected: 8/16/15
Died: 11/13/15
Cause: Mortalityp
Strain: NV-400
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Pen 7: HC-404
Affected: 6/1/15
Died: 8/19/15
Cause: Mortalityp
Strain: NV-400
Affected: 7/24/15
Died: 10/2/15
Cause: Mortalityp
Strain: NV-400
Affected: 6/15/15
Died: 9/3/15
Cause: Mortalityp
Strain: NV-400
Affected: 7/8/15
Died: NA
Cause: NA
Strain: NV-400
Affected: 7/9/15
Died: NA
Cause: NA
Strain: NV-400
Affected: 7/17/18
Died: NA
Cause: NA
Strain: NV-400

C

Born: 5/19/15
Affected: 5/27/15
Died: 6/15/15
Cause: Mortalityp
Strain: NV-400
Born: 5/26/15
Affected: 6/10/15
Died: 7/14/15
Cause: Mortalityp
Strain: NV-400
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Pen 8: HC-404
Affected: 8/1/15
Died: 12/3/15
Cause: Mortalityp
Strain: NV-400

C

Affected: 8/1/15
Died: 12/8/15
Cause: Mortalityp
Strain: NV-400

C

Affected: 8/9/15
Died: 11/13/15
Cause: Mortalityp
Strain: NV-400

C

Affected: 8/15/15
Died: 12/3/15
Cause: Mortalityp
Strain: NV-400

Born: 5/19/15
Affected: 6/10/15
Died: NA
Cause: NA
Strain: NV-400

C

Pen 9: NV-400
Affected:5/16/15
Died: 12/11/14
Cause: Mortalityo
Strain: NV-400

Born: 4/21/15
Affected: NA
Died: 4/22/15
Cause: Mortalityo
Strain: NA

Affected: 4/15/15
Died: 10/26/15
Cause: Mortalityo
Strain: NV-400

Born: 4/26/15
Affected: NA
Died: 4/27/15
Cause: Mortalityo
Strain: NA

Affected: 5/30/15
Died: NA
Cause: NA
Strain: NV-400

Born: 4/12/15
Affected: 4/29/15
Died: 5/21/15
Cause: Mortalityp
Strain: NV-400
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Pen 9: NV-400 (continued)
Born: 4/18/15
Affected: 5/9/15
Died: 5/22/15
Cause: Mortalityp
Strain: NV-400

Affected: 5/30/15
Died: 7/28/15
Cause: Mortalityp
Strain: NV-400
Affected: NA
Died: NA
Cause: NA
Strain: NV-400

Born: 3/24/15
Affected: 4/28/15
Died: 5/23/15
Cause: Mortalityp
Strain: NV-400

Affected: 8/18/15
Died: NA
Cause: NA
Strain: NV-400

Born: 5/8/15
Affected: 5/22/15
Died: 6/15/15
Cause: Mortalityp
Strain: NV-400

Affected: 5/24/15
Died: NA
Cause: NA
Strain: NV-400

Born: 5/20/15
Affected: 6/10/15
Died: 6/16/15
Cause: Mortalityp
Strain: NV-400

Affected: 1/13/15
Died: 7/17/15
Cause: Mortalityp
Strain: NV-400

C

C

Affected: 5/30/15
Died: 8/18/15
Cause: Mortalityo
Strain: NV-400

Born: 4/2/15
Affected: 5/1/15
Died: 6/28/15
Cause: Mortalityp
Strain: NV-400

Affected: NA
Died: NA
Cause: NA
Strain: NV-400
Affected: 5/14/15
Died: NA
Cause: NA
Strain: NV-400

Born: 6/5/15
Affected: 6/13/15
Died: 6/27/15
Cause: Mortalityp
Strain: NV-400

C
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APPENDIX D. WIND SPEED
Average daily wind speed and maximum wind gusts (km/h) recorded in Brookings, South Dakota, USA during early
indications of cross-strain infections.

120

Wind speed (km/h)

100
80
60

Average
Maximum gust

40
20
0
April-15

May-15

June-15

July-15
Date (2015)

August-15

73
CHAPTER 2: INVESTIGATING THE ROLE OF CHRONIC MYCOPLASMA
OVIPNEUMONIAE CARRIERS IN PNEUMONIA PERSISTENCE AND SURVIVAL
OF BIGHORN SHEEP LAMBS

This chapter is being prepared for publication and was coauthored by Daniel P. Walsh,
E. Frances Cassirer, Thomas E. Besser, and Jonathan A. Jenks.
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ABSTRACT
Mycoplasma ovipneumoniae (Movi)-induced pneumonia is a devastating
respiratory disease that has been implicated as the principal impediment to bighorn sheep
(Ovis canadensis) recovery for almost a century. Population-level effects of pneumonia
events range from mild to extirpation. Perhaps the greatest bighorn sheep recovery
concern, however, is recurrent annual lamb epizootics. We tested the hypothesis that
respiratory disease persistence within bighorn sheep populations is driven by chronically
Movi infected ewes, and its prediction that lambs born in pens with at least one chronic
carrier ewe (treatment) will experience Movi-induced pneumonia mortality whereas
lambs born in pens without a chronic carrier ewe (control) will not develop fatal
pneumonia. All lambs in treatment pens that survived > 10 days of age developed
respiratory disease, and 92% (n = 24/26) of these lambs experienced fatal Movi-induced
pneumonia. During persistent epizootic years of pneumonia, lambs born in control pens
failed to develop fatal pneumonia and 89% (8/9) survived. During an all-age pneumonia
epizootic, total lamb mortality was 88% (22/25). Movi-induced pneumonia caused 59%
(n = 13/22) of these mortalities and included 2 lambs in a single control pen. Nonpneumonia causes of lamb mortality were high (41% (n = 9/22)) during the all-age
epizootic, particularly for lambs < 10 days of age. Our models predicted the probability
of fatal pneumonia for lambs in treatment pens during all years (2014–2017) of our study
was >0.90 for two age periods:16–45 and 105–114 days after parturition. Further, the
age-varying log hazard of fatal pneumonia was at least twice as high for lambs in
treatment pens compared to lambs in control pens. It appears identification and removal
of chronic carriers from a population will aid bighorn sheep recovery efforts.
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INTRODUCTION
Pneumonia is a devastating respiratory disease that has been implicated as the
principal impediment to bighorn sheep (Ovis canadensis) recovery for almost a century.
Pneumonia has caused 75–100% mortality in some herds across western North America
(Rush 1927; Shannon et al. 2014; Sells et al. 2015; Cassirer et al. 2018). The primary
pathogen involved in bighorn sheep pneumonia epizootics is Mycoplasma ovipneumoniae
(Movi; Besser et al. 2008, Dassanayake et al. 2010, Besser et al. 2013). Movi is a native
microparasite of Old-World Caprinae, (e.g., domestic sheep (O. aries) and goats (Capra
hircus)), and these reservoir hosts typically carry infectious agents asymptomatically.
Contact with reservoir hosts precedes spillover epizootics (Foreyt and Jessup 1982,
Foreyt et al. 1994, George et al. 2008), and Movi has consistently been identified in fatal
bighorn sheep epizootics (Besser et al. 2012b, Besser et al. 2013, Cassirer et al. 2017).
Alternatively, captive bighorn sheep survive when commingled with Movi-negative
domestic sheep (Besser et al. 2012a, Kugadas 2014).
Pneumonia epizootics outwardly exhibit high all-age morbidity (Besser et al.
2014, Cassirer et al. 2017) and mortality. Cassirer et al. (2018) reported a median
population decline of approximately 50% (range 5–100%) for 82 bighorn sheep
pneumonia events. Bighorn sheep that survive epizootic pneumonia are generally
believed to be resistant to disease and may become healthy, but a small proportion
(median = 22%; Cassirer et al. 2018) may maintain or tolerate disease and persistently
carry Movi (Cassirer et al. 2013, Plowright et al. 2013). Pathogens usually persist,
presumably by chronic carriers, in free-ranging populations (Plowright et al. 2017,
Garwood et al. 2020).
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Bighorn sheep epizootic pneumonia is characterized by recurrent summer lamb
mortality. Pneumonia-induced lamb mortality between 4 and 14 weeks of age is common
and may last decades following the initial spillover infection (Singer et al. 2000,
Sirochman et al. 2012, Cassirer et al. 2013, Plowright et al. 2013, Manlove et al. 2014).
Outbreaks likely start with vertical transmission of pathogens from chronically infected
carrier ewes to their lambs (Hobbs and Miller 1992, Clifford et al. 2009, Cassirer et al.
2013), and subsequent lamb-to-lamb transmission within social nursey groups (Manlove
et al. 2014). Failure of lamb recruitment triggered by sustained recurrent lamb epizootics
result in declining and aging herds and may serve as the single most critical management
concern affecting bighorn sheep populations.
Several studies have documented negligible to catastrophic effects of recurrent
pneumonia-induced lamb mortality (Cassirer and Sinclair 2007, Smith et al. 2014, Butler
et al. 2018), but the causal mechanisms are inadequately understood. We attempt to
address this crucial knowledge gap in the first longitudinal, empirical study using captive
individuals collected from several wild populations (Fig. 1), each with unique knownMovi exposure histories (e.g., strains; Table 1). We present evidence of pneumonia
recurrence and mortality of bighorn sheep lambs during pneumonia epizootics that was
generally limited to lambs, herein lamb epizootic, which occurred in 2014, 2016, and
2017. We compare disease dynamics in these years to an all-age epizootic in 2015.
We hypothesized that respiratory disease could persist in a bighorn sheep
population through a small number of Movi carriers that drive disease transmission to
lambs. To test this hypothesis, we measured the effect of ewes of differing carrier status
on the health and survival of lambs. Our prediction was that lambs born in pens with at
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least 1 chronic Movi carrier ewe present (treatment) were more likely to show signs of
pneumonia and have lower survival than lambs born in pens without at least 1 chronic
Movi carrier ewe (control).
METHODS
Study Area
Our study was conducted at the South Dakota State University (SDSU) Captive
Wildlife Research Facility in Brookings, South Dakota (44°20´ N, 96°47´ W) ) using 39
adult bighorn sheep ewes transported from free-ranging populations in Washington (n =
15), Oregon (n = 5), Idaho (n = 2), South Dakota (n = 3) and Nevada (n = 14) and
animals ≥2 years of age (n = 10) born in captivity. Annual temperatures in the region
commonly vary from -29°C–38°C in the winter and summer, respectively, with a mean
temperature of 8°C annually (Spuhler et al. 1971). Mean regional precipitation ranges
from 33–63.5 cm, with snowfall varying from 63.5–114 cm (Spuhler et al. 1971). The
prevailing wind direction is from the south in the spring and the north-northwest during
the winter. Wind speeds can exceed 50 mph in the summer and winter, however, the
average annual wind speed in the region is 11 mph (Spuhler et al. 1971).
Captive animals were provided fresh alfalfa-grass mixed hay, pelleted soybean
hulls, water, and loose mineral ad libitum daily. Capture, transport, daily care, and
animal sampling protocols were reviewed and approved by the SDSU Institutional
Animal Care and Use Committee (Number 14-076A) and state wildlife departments.
Captive animal care met or exceeded the recommendations from the Sikes and Animal
Care and Use Committee of the American Society of Mammalogists (2016).
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Pre-study Sampling and Carrier Classifications
Prior to the initiation of our study, state wildlife departments routinely monitored
uniquely marked bighorn sheep for Movi prevalence in their respective wild herds. State
agency personnel collected nasal and oropharyngeal swabs and sent samples to the
Washington Animal Disease Diagnostic Lab (WADDL) for analysis. Using the state
wildlife department’s data, we reviewed available Movi PCR test results on nasal swabs
to assign individual sheep to an initial Movi carrier class prior to translocation to SDSU
(Appendix A). We classified individual sheep as negative (N), intermittent (I), or chronic
carrier (C), where N, I, or C classifications were based on that individual testing positive
for Movi 0%, 1–74%, or ≥ 75% of the time, respectively.
Following review and identification of individual bighorn sheep eligible for our
study, state wildlife departments selected and captured adults via chemical
immobilization or helicopter net-gunning from 7 source herds: Asotin, Black Butte,
Lostine, and Sheep Mountain (Hells Canyon Washington, Oregon and Idaho), Badlands
(South Dakota), Rapid Creek (South Dakota), and Snowstorm Mountains (Nevada; Fig.
1, Table 1) and immediately transported animals to SDSU and released them into a pen.
Captive Research Facility Design
Free-ranging bighorn sheep populations often have unique Movi strain exposure
histories (Cassirer et al. 2017, Cassirer et al. 2018). To prevent cross-strain
transmissions, we did not commingle adults from populations where different strains had
recently been detected. Considering the prevailing winds, we assigned negative sheep
pens to the west end of the research facility (Fig. 2). We designed our captive bighorn
sheep research pens so that pens were a minimum distance of 15.24 m where possible,
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particularly between Movi-positive and negative sheep (Fig. 2a). Further, we followed
strict biosecurity measures in an effort to prevent cross-strain transmissions including: (1)
the installation of disinfecting foot baths at each pen gate for use immediately prior to
entering and exiting each pen; (2) designation of feed and water pails specific to pen
assignment; (3) changed protective clothing when handling possible Movi-positive sheep;
and (4) entered pens strictly from west (Movi-negatives) to east (Movi-positives) daily
and consistently as pens were numbered (e.g., Pen 1 first, Pen 9 last; Fig. 2).
Microbiological Testing
Capture.–Following a ≥ 6 mo acclimation period, we chemically immobilized
(BAM; 0.43 mg/kg butorpahanol, 0.29 mg/kg, azaperone, 0.17 mg.kg mg/kg
medetomidine, Wildlife Pharmaceuticals) captive adults via dart rifle (Dan-Inject,
Børkop, Denmark, EU) at 4-6-week intervals from 1 October – 1 March annually.
Sampling and testing.–For pathogen detection, we collected duplicate nasal swab
samples by fully inserting each single polyurethane culture swab (BD CultureSwabTM EZ
System) sequentially into both nares of each animal, slowly rotating the swab shaft
against the nasal wall while withdrawing the swab, then replacing the swab in its sheath
and storing chilled (4C) or frozen (-20C) until received at the laboratory for detection of
Movi by realtime polymerase chain reaction (Cassirer et al. 2017). We collected 8-10 ml
blood via jugular venipuncture and extracted 0.5–1-ml serum for detection of antibodies
to Movi via competitive enzyme-linked immunosorbent assay (cELISA). We stored the
remaining serum at SDSU at -18°C. All samples were shipped to Dr. Thomas Besser’s
laboratory at Washington State University (Pullman, WA, USA). Dr. Besser transferred
serum samples to the Washington Animal Disease Diagnostic Laboratory (WADDL) for
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Movi cELISA analyses (Ziegler et al. 2014). We strain-typed all detected Movi by multilocus sequence typing as described in Cassirer et al. (2017).
Carrier class confirmation.–We used cumulative results of serial samples from all
individuals in our study to confirm adult Movi carrirer classifications. Due to acute
infection of adults subsequent indirect transmission, we defined N, I, and S carrier
individuals as those testing Movi- positive ≤33%, 34-66%, or ≥67% of the time,
respectively.
Experiments
Individuals of known carrier class (N, I, and C) were assigned to pens (Fig. 3)
based on confirmed Movi strain carriage to determine: (1) the effect of exposure to
chronic carrier individuals, and (2) lamb survival rates in the presence/absence of ewes of
different Movi carrier statuses. Our study was a switch-back design replicated across
source herds, where adult survival allowed.
In 2014, we designed 1 treatment pen (≥ 1 C carrier present) consisting of 3
Asotin ewes, and 2 had lambs. Alternatively, we had 1 control pen (absent of C carriers)
of 3 Lostine ewes, and all 3 had lambs. To review the effect of the exposure of I carrier
ewes on lamb pneumonia persistence and mortality, we limited 1 control pen to all N
ewes and 1 control pen to consist of mostly all I ewes from Black Butte using 4 bred
ewes in each pen. Comparatively, treatment pens in 2015 consisted of penning N, I, and
C from the same source herd. Specifically, we developed pens with N-C, I-C and only C
ewes from Hells Canyon subpopulations. Furthermore, we did not have pre-study serial
samples from Snowstorm ewes, so all ewes and the ram were penned together to develop
Movi carrier classifications in subsequent years. In 2016, we derived pen assignments
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based on recent exposure and Movi carriage using surviving ewes. We planned control
pens for both derived populations (Population 1: Strain 404, Population 2: Strain 400)
using 3 and 4 ewes, respectively. We had 5 lambs born to the 7 ewes in a control pen in
2016. We designed 1 and 3 treatment pens for Population 1 and 2, respectively. We had
5 lambs born to the 14 ewes housed in 2016 treatment pens. Finally, in 2017, we
designed 1 control pen, with 1 Population 1 ewe birthing 1 lamb. Comparatively, we
planned 1 and 3 treatment pens for Population 1 and 2, respectively, in 2017. We
assigned N-I-C, N-C, I-C, and only C treatment pens, and 8 lambs were born to the 10
ewes in the 2017 treatment pens (Fig. 3).
Lamb Monitoring and Mortality Investigation
Throughout the course of the study, we conducted daily clinical observations (≥
20-min) of each pen to monitor respiratory disease transmission, persistence, and
recovery of lambs. Symptoms recorded were: inappetence, lethargy, cough, nasal
discharge, ear paresis, nose licking, weakness/recumbency, and head shaking. Symptoms
observed were scored 0–10, which ranged from not-observed to severe. Lambs that were
moribund were euthanized following our IACUC protocol. All lambs that were
euthanized or expired naturally in our study were shipped overnight to WADDL for
complete necropsy, histologic evaluation, bacteriologic culture, and Movi gene analyses
methods as outlined in Besser et al. (2008). Following thorough diagnostic investigation,
cause of death was assumed known with certainty. We classified mortality causes as one
of the following: pneumonia, contagious echthyma, gastrointestinal disease, neonatal,
stillbirth, or abortion.
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Statistical Analyses
We used Bayesian hierarchical models to estimate the hazard rates and treatment
impacts of the presence of at least one Movi chronic carrier on lamb survival.
Specifically, we used a 2-component model: one that describes lamb age at death, and
one that describes the cause of death, which is assumed to be known with certainty (Cross
et al. 2015, Walsh et al. 2018). We considered cause-specific mortality to be 1 of 2
possible classes: pneumonia or non-pneumonia related death.
Each lamb that died during our study contributed the following term (Li) to the
likelihood:
ai

Li = Pr (𝑎𝑖 < A < (ai + ∆), Ki = k|A > ai )= hi (ai ) exp (- ∫ hi (a) da) × πi,k ,
0

which was the joint probability of the ith individual’s age at death occurring in the interval
[ai, ai + ∆] and the cause of death was cause k. We modeled the age at death by the
hazard function hi(a), and the probability of dying of cause k was πi,k .
Individuals that survived the entire study were right censored and made the
following contribution to the likelihood:
ai

Li = Pr (ai < A) = exp (- ∫ hi (a) da).
0

To allow for interval-censoring of the age at death, we used the following
approximation to Li:
Li = Pr (ei < A < ri , Ki = k|A > ei )
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si

ri

≈ (1 - exp (- ∑ ψa,i )) × exp (- ∑ ψa,i ) × πi ,k,
a=ri

a=ei

where ei was the age the individual entered the study (i.e., 1), ri was the age it was last
known to be alive, and si was the age it was confirmed dead. The unit cumulative hazard
a+1

rate is represented by the term ψa = ∫a

h (a) da.

For various covariate effects on the death hazard rate, we used a log-linear model
to estimate the proportional hazard effect of covariates using:
ln (ψa,i ) = βxi + (1 - I15 ) δa + I15 (β15 xi + δ15,a ),
where β represents the hazard ratio associated with xi, the indicator variable of whether a
lamb was born in a pen with a chronic carrier(s), δa is a smoothed effect for the ath age
interval, I15 was an indicator for the lamb being born during 2015, β15 is the hazard ratio
associated with xi, an indicator of commingling a lamb with a chronic carrier(s) in 2015,
and δ15,a was a smoothed effect for the ath age interval in 2015, which allowed the model
to account for differences in lamb survival during an unplanned cross-strain transmission
event in 2015. Our model was parameterized such that the β15 represented an additive
effect to β, and the smoothing effects were distinct between 2015 and other years in our
study.
We used a logit link function to assess the impact of commingling a lamb with a
chronic carrier(s) in the probability of a lamb dying from pneumonia:
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logit (πi,k ) = α0 + (α+ζa ) × xi
i

where α0 was the effect of dying of pneumonia, α was the treatment effect of
commingling of lambs with chronic carrier(s), and ζ ai is the spline smoothing effect for
the ith lamb’s age at death when born in a treatment pen, and we enforced a sum-to-zero
constraint,
∑ ζl = 0.
l

We used B-spline basis functions as implemented in the splines package in R (R
Core Team 2018) to create the basis vectors for the ζ ai parameters. We assumed that
lambs born in a control pen (absent of ≥ 1chronic carrier(s)) had a constant probability of
dying from pneumonia. Combining the various portions of the model produces the full
likelihood (L) for all N individuals:
N

L = ∏ Li .
i=1

To complete the Bayesian model, we specified a diffuse Normal (0, σ2 = 100)
prior for each of the ⃗β and 𝛼 parameters. For the smoothed age effects, we used a
random walk or an intrinsically conditional autoregressive (ICAR) prior:
1

Pr = (δa |δ-a , τa ) ~N (M ∑
a

jϵNa

δj' Ma τa ),

where δ−a were all ages except a, Μa was the number of neighboring ages for age a, Νa
was the set of all ages for which j was a neighbor of age a, and τa was the precision term.
We used a Gamma (1, 1) hyperprior for precision. We used a unique random walk prior
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for δ15,a using the same procedure. Each of the above priors are specified in the BUGS
language format (Lunn et al. 2000).
The posterior distribution was then defined as:
Pr (θ⃗ |data) = L × ∏k [θk ]
where 𝜃 is the vector of parameters and [θk] was the prior distribution for the kth
parameter.
To estimate the posterior distributions of our parameters of interest, we used
Markov Chain Monte Carlo (MCMC) methods using Nimble in Program R (NIMBLE
Development Team 2018, R Core Team 2018, Walsh et al. 2018). We ran 3 chains for
200,000 repetitions, and removed the first 20,000 iterations for burn-in. Each chain was
initialized with dispersed starting values, and we looked for evidence of non-convergence
by assessing diagnostic plots and calculating the Gelman-Rubin statistic for each
parameter with the exception of the ⃗⃗⃗
δa parameters. If the 95% upper bound of the
Gelman-Rubin statistic for the parameter was ≤ 1.1, we considered that there was no
evidence for lack of convergence.
Posterior predictive checks
To assess how well our hierarchical model fit these data, we used the quantiles of
the observed lamb ages at mortality as test statistics. Using a randomly selected sample
from the joint posterior distribution of the parameter in combination with individual
covariates, we stochastically generate an age at death for each individual in the study.
We then calculated the 10–90% quantiles for these ages and replicated this process 1000
times.
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We used the following formula to calculate a sampled Bayesian p-value for the lth
quantile:
M

P =∑

I(Tl,obs < Tl,m )
M

m=1

where Tl,obs is the observed lth quantile for age at death, Tl,m is the estimated lth quantile
based on the mth replicate, and M is the total number of replicates used. To jointly assess
the model’s fit for the overall hazard and cause-specific probabilities, we repeated this
process but only used the ages of lambs that died of pneumonia, and also calculated the
probability of dying from pneumonia. For the latter statistic, we used the above equation
to calculate the Bayesian p-value, but Tl,obs is the observed probability of a lamb dying of
pneumonia and Tl,m is the estimated probability based on the mth replicate.
RESULTS
When all mortality causes were pooled across all years of our study, the
percentage of lamb mortality was more than twice as high when lambs were in born in
pens containing at least one Movi chronic carrier ewe (treatment), compared to when
only Movi negative and/or intermittent ewes were present in the pen (control; 92% (n =
33 of 36) and 38% (n = 5 of 13). We define years 2014, 2016, and 2017 in our study as
periods when there was no transmission among pens, and pneumonia mortality was
limited to lambs (lamb epizootics). In these years, overall lamb mortality attributed to all
causes was 70% (n = 16), with 94% (n = 15) of these being lambs born in treatment pens
(Fig. 3). Consistent with our hypothesis, no lambs born in control pens developed or died
of pneumonia in these years of our study (Fig. 3).
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In 2015, presumed aerosolized Movi caused unexpected cross-strain
transmissions across pens and a subsequent all-age pneumonia epizootic with 88% (n =
22/25) of all lambs expiring prior to weaning. Of the 2015 lambs that died, 82% (n = 18)
were born in a treatment pen with at least one Movi chronic carrier ewe (Fig. 3). During
the all-age pneumonia epizootic, all lambs born in a control pen expired prior to weaning,
but 50% (n = 2) developed and died of pneumonia at 49 and 107 days of age. The other
50% (n = 2) developed gastrointestinal disease and died of malnutrition at 20 and 51 days
of age (Fig. 3), and we failed to detect Movi during diagnostic review of these mortality
samples.
Average lamb age at death due to confirmed pneumonia-related mortality was 52
days (n = 2; range = 42 – 62), 56 days (n = 13; range = 22–107 days), 41 days (n = 4;
range = 15–79), and 48 days (n = 7; range = 15–113 days) in 2014, 2015, 2016, and 2017,
respectively. When pooling lamb mortalities, we recorded more than 8 times as many
confirmed pneumonia-related lamb mortalities (n = 24; 68%) than any other single cause
(Fig. 4). Other causes of bighorn sheep lamb mortality in our models were contagious
ecthyma (n = 3; 8%; mean age = 91 days; range = 79 – 102), and gastrointestinal diseases
(e.g., Clostridial disease; n = 3; 8%; mean age = 27 days; range = 9–51). Neonatal,
(lambs < 5 days old; n = 3; 8%), dead at birth (n = 3; 8%; Fig. 4) were removed from our
analysis but still warrant discussion. Eleven (23%) of 47 total lambs in our study
survived to weaning. Four (36%) of the surviving lambs showed clinical signs of
pneumonia and all were Movi positive at their first conventional health sample (October
of their birth year). Two of these surviving lambs were in treatment pens (2015), and two
were in control pens (2015 and 2016).
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Overall Mortality Hazard
The overall log mortality hazard (log hazard hereafter), defined as the rate at
which lambs expired from any cause prior to weaning in our study, was significantly
lower during years of expected typical pneumonia epizootics than during the unexpected
all-age outbreak (Fig. 5). The mean daily rate at which lambs died of all causes during
years of typical pneumonia epizootics was slightly above zero and did not significantly
vary by age. The estimated posterior distribution presented in our model indicated the
highest mortality hazard during these years was 87 days of age. The estimated mean of
the precision for the smoothed age effects was 3.65 (SD = 1.71, LCI = 1.17, UCI = 7.79;
Table 2). In contrast, the overall log mortality hazard during the all-age pneumonia
epizootic was higher and more variable (Fig. 5). The mean estimated posterior
distribution during this year (2015) indicates an age-varying mortality process occurred.
Our model indicated the log hazard is highest at ages 1–3 days (e.g., neonatal mortality; n
= 4) with secondary peaks at 38 days of age, which was the median age at death and 100–
108 days of age (Fig. 5). During 2015, 14% (n = 3) of lambs that died prior to weaning
exceeded 100 days of age. The estimated mean of the precision for the smoothed age
effects was 2.15 (SD = 1.19, LCI = 0.59, UCI = 5.14; Table 2).
Our model estimated commingling increased the log hazard during lamb epizootic
pneumonia (i.e., non-2015 years). The rate of lamb mortality occurred significantly
faster when a lamb was born in a treatment pen (mean log hazard = 2.80; SD = 0.78, UCI
= 1.37, LCI = 4.40; Table 2).
During the all-age pneumonia epizootic in 2015, there was a negative effect on
the estimated log hazard if a lamb was born in a treatment pen with at least one chronic
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Movi carrier adult (mean log hazard = -2.36, SD = 0.90, LCI = -4.16, UCI = -0.62; Table
2). We documented 4 lambs infected with a Movi strain type that differed from those
carried by ewes prior to 2015 lambing. However, the 2 control lambs expired from a
strain previous carried by their dams in the wild. Further, 1 lamb born in a treatment pen
that year and survived carried a novel strain type at the first sample post-weaning
(October 2015).
Conditional Probability of Pneumonia
Confirmed pneumonia-induced lamb mortality was recorded as the cause of 85%
(n = 22) over 3 years and 59% (n = 13) of all lamb deaths during expected typical
pneumonia epizootics and an all-age pneumonia epizootic (1 year), respectively. The
mean posterior parameter estimate for the probability that individual’s death was due to
pneumonia on the logit scale was -1.01 (SD = 0.80, LCI = -2.74, UCI = 0.45; Table 2).
Given a lamb died, our model estimated the probability of dying of pneumonia was
highest at lamb ages 16–61 and ≥ 98 days of age (Fig. 6). The mean of the precision for
the spline smoothing effect on the conditional probability of pneumonia mortality was
0.15 (SD = 0.27, LCI = 0.01, UCI = 0.80; Table 2).
Our model estimated the probability the cause-of-death was pneumonia was
higher for lambs born in a treatment pen with a Movi chronic carrier compared to those
that were born in a control pen without a Movi chronic carrier (mean = 3.50, SD = 1.30,
LCI = 1.28, UCI = 6.39; Table 2). The mean probability of pneumonia-induced mortality
for lambs born in a treatment pen was above 0.75 by 15 days of age and generally
remained above that level for the duration of the study. Our model also estimated this
probability to be elevated (≥ 0.90) as early as 16 days of age until 45 days of age, and a

90
secondary peak for older, nearly weaned, lambs (105–114 days of age). Confirmed
pneumonia-specific mortality was not likely for lambs less than 14 days of age (Fig. 7).
Pneumonia Hazard
The effect of commingling lambs with at least one Movi chronic carrier had a
substantial influence on the age-varying pneumonia hazard of captive bighorn sheep
lambs in years without an all-age epizootic (Fig. 8). Pneumonia-induced mortality hazard
was significantly lower for lambs not directly exposed to a chronic carrier. Age-varying
mean pneumonia mortality hazard for lambs that were born in a control pen was low but
peaked at approximately 0.001 around 90 days of age. In contrast, when born in a
treatment pen with a chronic carrier ewe, lamb pneumonia hazard increased at least 2fold by 15 days of age and remained higher than the hazard of the lambs born in a control
pen for all subsequent ages during our study (Fig. 8).
Posterior Predictive Checks
Although it appears that the model estimated ages of death may be slightly lower
than those observed, all Bayesian p-values derived for age at death for 10–90% quantiles
fall within the interval [0.05, 0.95], which demonstrated no evidence for significant lack
of fit (Table 3). Similarly, the p-values for 10–90% quantiles for age at death for lambs
dying of pneumonia did not indicate a lack of fit (Table 3), nor did the test statistic for the
probability of a lamb dying of pneumonia, which had a p-value = 0.079.
DISCUSSION
To date, this is the first formal longitudinal captive experiment using a priori
intensively sampled known individuals from multiple free-ranging populations aimed to
identify Movi carrier class, persistence and associated impacts on lamb survival.
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Consistent with our hypothesis, a high proportion of lambs experienced fatal pneumonia
when born in a pen with at least 1 chronic carrier. Simultaneously, lambs failed to
develop respiratory disease altogether or cleared infection and remained healthy in the
absence of chronically infected adults. The proportion of lambs that died during our
study, regardless of confirmed cause, was more than twice as high when born into a
treatment pen and was directly exposed to at least one Movi chronic carrier than when
born in a control pen and exposure was limited to negative and/or intermittent Movi
carriers.
Our study provides additional support for the premise that chronic Movi carriers
serve as the source of pathogen transmission that initiates fatal pneumonia outbreaks in
lambs in free-ranging populations. If even a small proportion of ewes are chronic
carriers, pathogen transmission occurring by dam-lamb interaction is then amplified by
transmission within lamb nursery social contact networks. Preliminary findings from a
parallel captive study at Washington State University reported all (n = 2) lambs born in a
pen with a single chronic Movi carrier developed and died from pneumonia; whereas, all
(n = 4) lambs born in a pen with Movi-negative ewes remained non-pneumonic and
survived (Weyand et al. 2018). A metapopulation of free-ranging bighorn sheep in Hells
Canyon experienced a higher proportion of lamb mortality for lambs born to chronically
infected ewes as compared to negative and/or intermittently infected ewes (Plowright et
al. 2017). Further, Garwood et al. (2020) failed to detect Movi and associated
pneumonia-induced lamb mortality following the removal of chronic carriers from a freeranging population in South Dakota.
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Only 6% (n = 2) of lambs born in a pen with a chronic Movi carrier ewe survived
in our study. One of these lambs displayed severe signs of respiratory disease, was
generally lethargic and exhibited stunted growth; whereas, the other lamb presented mild
indications of clinical respiratory disease but otherwise appeared healthy. Both of these
surviving lambs were subsequently Movi positive in serial samples, meeting the
definition of a chronic Movi carrier, but eventually succumbed to pneumonia by 2 years
of age. It is plausible that lambs that survive neonatal Movi infection and are unable to
clear the infection are an important source of chronic Movi carriers for wild populations,
hindering bighorn sheep recovery.
Other studies document low survival of offspring when exposed to Movi (Smith
et al. 2014, Plowright et al. 2017, Garwood et al. 2020). Movi-positive bighorn sheep
herds in South Dakota documented 2% and 11% lamb survival to recruitment (Smith et
al. 2014, Garwood et al. 2020). Our study supported many reports of peak pneumoniainduced lamb mortality occurring between 30 and 100 days of age (Ryder et al. 1992,
Enk et al. 2001, Smith et al. 2014, Garwood et al. 2020). Our study supports Wood et al.
(2017) in documenting the pneumonia-induced mortality in younger captive lambs (≤ 15
days of age; n = 2). The younger lamb fatal cases in our study had limited or no clinical
disease but experienced abrupt lethargy and subsequent rapid morality as noted by Wood
et al. (2017). Alternatively, fatal cases in lambs 16–65 days of age (n =16) caused by
pneumonia experienced disease characterized by coughing, nasal discharge, and/or ear
paresis first evident by approximately 14 days of age and rapidly progressing until
mortality; whereas, older-aged pneumonia-caused fatal cases (≥ 65 days of age; n = 6)
had a prolonged disease course that was generally characterized by a delayed (≥35 days)
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onset of clinical symptoms, even if born in a pen with a Movi chronic carrier. For olderaged lambs that died of pneumonia, the disease course and subsequent progression of
coughing, nasal discharge, and/or ear paresis was gradual until mortality. The variability
of disease progression in juveniles may partially explain some of the dynamics of this
devastating disease reported in free-ranging populations. The period of disease in which
symptoms were not apparent for older lambs may have implications for disease detection
because they may appear healthy for several weeks or months following parturition.
Recent research and management observations reveal Movi strains (genotypes)
vary in pathogenicity (Felts et al. 2016, Justice-Allen et al. 2016, Cassirer et al. 2017).
Of the younger-aged pneumonia confirmed mortalities, 100% (n = 2) were the result of
infection with the NV-400 Movi strain, which was initially carried by the Snowstorm
(Nevada) sheep in our study. Comparatively, 83% (n = 5) of the older-aged pneumoniacaused fatal cases documented in our study were caused by the HC-404 Movi strain
initially carried by the Hells Canyon (Idaho, Washington, Oregon) bighorn sheep (Table
1). Furthermore, all (n = 6) lambs that survived the presence of an adult Movi chronic
carrier for >100 days of age carried the HC-404 Movi strain. Although anecdotal, this
suggests that Movi strains in our study may vary in virulence or that some maternal
immunity may have increased protection, in some cases. Another explanation for these
young-aged pneumonia-induced mortalities may be the result of pathogenic secondary
infections (e.g., Mannheimia haemolytica) following Movi colonization. Although crossstrain transmissions occur in free-ranging populations (Justice-Allen et al. 2016, Cassirer
et al. 2017), it is unlikely that any wild bighorn sheep population will face multiple
simultaneous strain challenges as presented in our study (Table 1; Fig. 2a).
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Alternatively, strain type virulence may not explain the anecdotal observations of
abrupt mortality and prolonged survival of lambs infected with the NV-400 and HC-404
strains, respectively. The clinical stage of infection of the infectious individual(s)
carrying these two strains and transmitting them to the lambs may explain, or work in
concert with strain virulence, to drive observed disease dynamics. Acutely infected (e.g.,
symptomatic) adults would present lambs with a higher pathogen load compared to
asymptomatic chronic carriers. Disparity exists between acute and chronic shedding rates
(Pathak et al. 2010). Due to the acute infection attributed to indirect cross-pen
transmission during 2015, animals that were not chronic carriers became infected.
However, subsequently, when the chronic carriers were separated out, most non-carriers
cleared infection and remained healthy.
Movi is highly transmissible, and direct contact is not required for epizootic
spread of pneumonia in captive bighorn sheep studies (Besser et al. 2014; Felts et al.
2016). During an all-age pneumonia epidemic, a control pen (Pen 1) with adults and
lambs penned together were indirectly exposed to Movi, or the adults were indirectly
exposed then directly exposed lambs. Lambs born control pens only succumbed to fatal
pneumonia when our study experienced an unintentional all-age fatal pneumonia
epizootic in 2015. During this period, negative ewes become indirectly and acutely
infected with a novel Movi strain (Appendix A; Felts et al. 2016). Laboratory analyses of
Movi and subsequent strain typing of conventional health and environmental samples
allowed us to confirm cross-strain transmissions, which we attributed to infectious
aerosols generated by coughing infected animals in other pens. During this period in our
study, 2 lambs born in Pen 1 (control) succumbed to gastrointestinal disease by July 20,
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2015. Neither lamb presented indication of pneumonia during daily observations or
necropsy, and both were Movi-negative by PCR and seronegative at the time of their
death (Table 4). The remaining 2 lambs born in Pen 1 developed and succumbed to
pneumonia by September 5, 2015. Pneumonic lambs exhibited severe indications of
respiratory disease during daily observations and severe lesions at necropsy and were
Movi-positive by PCR and seropositive upon laboratory evaluation of mortality samples
(Table 4). Therefore, we surmise the individuals in the control pen (Pen 1) were
indirectly infected after birth with aerosolized Movi following the non-pneumonic lamb
mortalities in that pen by July 20, 2015.
Our study corroborates Garwood et al. (2020)’s anecdotal interpretation in which
some cases of intermittent carriage can be attributed to cross-strain transmissions. The
contribution of intermittent carriers to pathogen persistence remains unknown. Review
of the stability of Movi carrier classifications was not possible due to the severe outbreak
that occurred in 2015 and further concerns of aerosol transmission. The degree of carrier
classification consistency remains unclear and warrants careful study. If these
classifications fluctuate (i.e., intermittent carriers become chronic carriers), targeted culls
of intermittent carriers may also be necessary for bighorn sheep recovery.
MANAGEMENT IMPLICATIONS
Our study underscores the importance of chronic Movi carriers in the long-term
persistence of pneumonia and associated depression of lamb survival, which are the
principal threats to bighorn sheep recovery. A high proportion (92%) of all lambs did not
survive when born in a pen with a chronic Movi carrier ewe. Both direct and indirect
transmission may present managers with cases of prolonged clinical disease progression
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and low lamb recruitment. Our study also demonstrates that targeted individual adult
hosts can disproportionately affect populations. Therefore, it is critical to longitudinally
sample individuals to identify those that are critical in driving disease dynamics. A freeranging population that harbors even a small proportion of adult chronic Movi carriers
may present wildlife managers with a stagnant or declining bighorn sheep population due
to limited-to-no annual lamb recruitment. Management should continue to prioritize
resources that target and remove chronic Movi carriers and prevent spillover of novel
Movi strains, which cause all-age pneumonia outbreaks.
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Table 1. South Dakota State University captive bighorn sheep source herds, Mycoplasma
ovipneumoniae genotypes (strain) defined in our study includes source herd identification
(HC: Hells Canyon; BB: Black Butte; SD: South Dakota; NV: Nevada), and number of
adult bighorn sheep used in our study.

Source Herd
Hells Canyon
Asotin
Lostine
Sheep Mountain
Black Butte
South Dakota
Rapid Creek
Badlands
Nevada
Snowstorm

Movi Strain

n

HC-404
HC-404
HC-404
BB-393

7
5
2
8

SD-398
SD-398

1
2

NV-400

14

TOTAL

39
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Table 2. Posterior parameter estimates including the mean, standard deviation (SD), 95%
lower credible limit (LCL), and 95% upper credible limit (UCL). Parameter estimates
presented below include an effect in which lambs were born in a pen with at least 1
Mycoplasma ovipneumoniae (Movi) chronic carrier (treatment), an all-age pneumonia
outbreak that occurred across pens during presumed acute disease of ewes (2015), and
Movi-induced fatal pneumonia for bighorn sheep lambs.
Parameter estimate
Treatment effect-log hazard
Precision-age log hazard
Treatment effect 2015-log hazard
Precision-age log hazard 2015
Probability of pneumonia-logit
Precision-probability of pneumonia-logit
Pneumonia-logit treatment

Mean
2.80
3.65
-2.36
2.15
-1.01
0.15
3.50

SD
0.78
1.71
0.90
1.19
0.80
0.27
1.30

LCL
1.37
1.17
-4.16
0.59
-2.74
0.01
1.28

UCL
4.40
7.79
-0.62
5.14
0.45
0.80
6.39
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Table 3. Bayesian p-values derived from posterior predictive checks, which assess how well the hierarchical models for lamb
ages at mortality fits these data. Quantiles of 10–90% are presented and for the interval (0.05, 0.95).
Predictive parameter

10%

20%

30%

40%

50%

60%

70%

80%

90%

Age at death
Age at death for
pneumonia mortality

0.625

0.668

0.801

0.824

0.946

0.886

0.834

0.773

0.136

0.414

0.421

0.464

0.463

0.543

0.676

0.371

0.282

0.127
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Table 4. Cause of mortality for lambs born in a control pen (no Movi chronic carrier present). Movi PCR cycle results ≤ 36.0,
36.1–39.9, and 40 indicate a positive, indeterminate, and negative sample, respectively. Movi ELISA ≤ 50% inhibition
represents a seropositive test. Movi ELISA test results of “NA” indicates analysis was not conducted for that individual.

Year Population Pen
2015
3
1
2015
3
1
2015
3
1
2015
3
1
2016
1
393

Ewe
Movi class
Negative
Negative
Negative
Negative
Negative

Mortality cause
gastrointestinal disease
gastrointestinal disease
pneumonia
pneumonia
contagious ecthyma

Age
(days)
20
51
49
109
91

Date
11 July
20 July
24 July
5 September
19 August

Movi
PCR
40
40
17.22
18.54
40

Movi
ELISA
67.789
-14.219
NA
86.391
NA
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Figure 1. Wild bighorn sheep source herds selected for translocation to the South Dakota
State University Captive Wildlife Research Facility, Brookings, South Dakota.
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Figure 2. Captive bighorn sheep research facility design and pen assignments based on known-Mycoplasma ovipneumoniae
(Movi) history and confirmed prior to parturition in 2014–2017. Longitudinal Movi strain types were the basis of pen
assignments and are presented. Movi carriage by PCR is presented as positive ((+)) or negative ((-)). Adult bighorn sheep sex
types are outlined: ewes (E) or rams (R).
2014

111
2015

112
2016–2017
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Figure 3. Experimental commingling pen assignments of bighorn sheep ewes by Mycoplasma ovipneumoniae (Movi) strain
types and carrier classifications: Negative (N), Intermittent (I), or Chronic (C). Twenty-four lambs were born in 14 pens during
a chronic carrier experiment (2014, 2016, and 2017) and 25 lambs were born in 6 pens in 2015 the year of a pneumonia
outbreak that occurred when Movi was transmitted across pens. Lamb fate is represented as survived to weaning (open circle),
pneumonia mortality (black circle), or non-pneumonia mortality (grey circle). Cause-specific mortality was confirmed at
necropsy. Treatment (lambs were born in a pen with at least one Movi chronic carrier) pen assignments are denoted by the
pink solid bordered area; whereas, control assignments (lambs were born in a pen without at least one Movi chronic carrier)
are the blue dashed images.
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*indicates ewes experienced a novel infection and were acutely infected with Movi strain 404 (Population 1 in subsequent
years of the study)
** indicates ewes experienced a novel infection and were acutely infected with Movi strain 400 (Population 2 in subsequent
years of the study)
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Figure 4. Cause-specific mortality of 39 captive bighorn sheep lambs from 2014–2017. We followed necropsy protocols on
fresh cadavers to investigate and confirm all sources of mortality. Gastrointestinal diseases included necrotizing colitis and
diarrhea. Neonatal mortality was classified as full-term lambs that had taken at least one breath and was less than 5-days old.
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Figure 5. Age-varying overall log hazard rate of 39 bighorn sheep lamb mortalities due to
any cause during lamb epizootic pneumonia with the absence of Mycoplasma
ovipneumoniae transmissions among pens (non-2015 years of the study) and during an
all-age pneumonia epizootic across pens (2015) at the South Dakota State University
captive bighorn sheep facility. Lamb age is presented as days after birth, and shaded
areas denotes 95% credible intervals.

117
Figure 6. Age effect for the logit probability of mortality attributed to pneumonia for 24
captive bighorn sheep lambs from 2014–2017.
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Figure 7. Age-varying probability of pneumonia-related mortality when bighorn sheep
lambs are born in a treatment pen with at least one Mycoplasma ovipneumoniae chronic
carrier ewe.
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Figure 8. Age-varying log hazard rate of mortality attributed to pneumonia for bighorn
sheep lambs born in a treatment pen with at least one Mycoplasma ovipneumoniae
chronic carrier present or control pen without a Mycoplasma ovipneumoniae chronic
carrier present. Age is presented as days after birth, and shaded areas denotes 95%
credible intervals.
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APPENDIX A. Pre-study Data, Carrier Classification, and Additional Serial Samples
Monitoring efforts for Mycoplasma ovipneumoniae (Movi) were conducted by state wildlife agencies prior to
translocation to South Dakota State University (SDSU). Individual sampling events with source herds listed as “-SDSU”
indicate the sampling event for capture of that individual, translocation, and entering our captive study at SDSU. Adult
bighorn sheep sex is indicated as “F” (female) or “M” (male). Estimated ages for individuals and sample dates are described.
We removed state’s serial samples collected ≤ 3 months from previous sample to minimize biasing Movi classification of
individuals for our study. The evaluation of Movi exposure for free-ranging populations by wildlife managers is common, and
ELISA percent inhibition > 50% indicates detection for that sampling event. Finally, individual Movi detection in serial
samples prior to the study are presented.
For Movi classification of the 40 adult bighorn sheep in our captive study, we reviewed Movi PCR results prior to the
study and classified individuals as a Negative, Intermittent, or Chronic Movi carrier. Classifications were based on that
individual testing positive for Movi < 0%, 1–74%, or ≥ 75% of the time prior to the lambing period of the individual’s entry
year into the study, respectively. For Movi classification purposes, we considered indeterminate Movi PCR results as
detections and are indicated as “I-Yes” because it was unknown what PCR cycle threshold was considered a detection (i.e.,
34th cycle or 36th) at that sampling event. Pen assignments were based on Movi classifications and population (“Pop.”) number
(Fig. 3).
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We also offer sample results for individuals following the lambing period of their entry year to confirm Movi carriers
and assess potential exposure to lambs. We also describe serial samples for some Negative classified Movi carriers during an
acute infection which occurred during an all-age pneumonia epidemic in 2015. For these individuals, an * indicates that all
remaining serial samples (2015–2017) failed to detect Movi. Finally, serial samples for rams (M) are described.

Pre-Study Data
Animal
Name
Mildred
Mildred
Mildred
Mildred
Elsie
Elsie
Elsie
Elsie
Ronda
Ronda
Ronda
Ronda
Nora
Nora
Nora
Nora
Ruby

Sample
Herd
Lostine
Lostine
Lostine-SDSU
SDSU
Lostine
Lostine
Lostine-SDSU
SDSU
Lostine
Lostine
Lostine-SDSU
SDSU
Asotin
Asotin
Asotin-SDSU
SDSU
Asotin

Sex
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F

Estim.
Age
14.6
14.7
15.8
16.5
11.7
12.7
12.8
13.5
4.6
4.8
5.8
6.5
4.4
5.5
5.8
6.5
4.6

Sample
Date
12/31/12
1/31/13
2/26/14
10/30/14
1/31/13
1/14/14
2/25/14
10/30/14
12/13/12
3/1/13
2/26/14
10/30/14
10/4/12
11/26/13
2/26/14
10/30/14
12/19/13

Study Classification
Movi
ELISA (%)
87.09
82.40
74.84
50.73
91.08
86.78
73.92
76.96
86.98
80.90
69.87
61.57
57.20
63.92
67.63
6.08
72.54

Movi
PCR +
Yes
Yes
Yes
Yes
Yes
Yes
I-Yes
I
Yes
Yes
No
No
No
No
No
No
No

Movi
+ (%)

Movi
Class.

Pen Pop. Entry
#
#
year

100

Chronic

7

1

2014

100

Chronic

7

1

2014

67

Intermittent

7

1

2014

0

Negative

1

1

2014
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Ruby
Ruby
None
None
None
Mamie
Mamie
Mamie
Mamie
Mamie
Crash
Crash
Crash
Crash
Crash
Abby
Abby
Abby
Abby
Boots
Boots
Boots

Asotin-SDSU
SDSU
Asotin
Asotin-SDSU
SDSU

Lostine
Lostine
Lostine
Lostine-SDSU
SDSU
Asotin
Asotin
Asotin
Asotin-SDSU
SDSU
Lostine
Lostine
Lostine-SDSU
SDSU
Asotin
Asotin-SDSU
SDSU
Sheep MtnCalamity SDSU
Calamity SDSU
Calamity SDSU
Sheep MtnAnnie
SDSU
Annie
SDSU

F
F
F
F
F

4.6
5.8
6.4
7.8
8.5

2/26/14
3/19/14
10/4/12
2/26/14
10/30/14

82.70
70.88
65.66
84.16
NA

No
No
No
No
No

0

Negative

1

1

2014

0

Negative

1

1

2014

F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F

12.6
12.7
13.7
14.7
14.9
10.6
10.8
11.5
11.7
11.9
12.8
13.7
14.7
14.8
4.8
5.7
5.7

12/13/12
2/6/13
1/15/14
1/13/15
10/5/15
12/30/13
2/26/14
11/12/14
1/14/15
3/19/15
3/7/13
1/15/14
1/13/15
11/9/15
2/26/14
1/14/15
11/9/15

90.49
91.08
80.34
69.19
45.99
81.31
86.81
75.60
70.86
58.71
89.61
88.15
70.44
87.93
91.19
42.83
83.75

No
No
No
Yes
Yes
No
Yes
I-Yes
Yes
I
Yes
Yes
Yes
Yes
I-Yes
Yes
Yes

25

Intermittent

3

1

2015

75

Chronic

3

1

2015

100

Chronic

8

1

2015

100

Chronic

8

1

2015

F
F
F

18.7
18.9

2/5/15
3/18/15
10/30/15

52.70
58.43
76.55

Yes
Yes
Yes

100

Chronic

8

1

2015

F
F

10.7
10.8

2/5/15
3/18/15

72.55
77.51

Yes
I

100

Chronic

8

1

2015
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Annie
Dolly
Dolly
Dolly
Dolly
Dolly
Dolly
Dolly
Amelia
Amelia
Amelia
Amelia
Amelia
Amelia
Diva
Diva
Diva
Diva
Diva
Diva
Diane
Diane
Diane
Diane
Patsy

SDSU
Black Butte
Black Butte
Black ButteSDSU
SDSU
SDSU
SDSU
SDSU
Black Butte
Black ButteSDSU
SDSU
SDSU
SDSU
SDSU
Black Butte
Black ButteSDSU
SDSU
SDSU
SDSU
SDSU
Black Butte
Black ButteSDSU
SDSU
SDSU
Black Butte

F
F
F

3.5
5.8

10/30/15
11/30/11
2/27/14

82.59
3.23
82.28

Yes
No
No

10/8/14
2/20/15
3/18/15
9/8/15
11/25/15
2/27/14

83.85
83.32
77.05
84.97
83.75
65.34

No
No
No
Yes
No*
No

0

Negative

1

3

2015

10/8/14
2/20/15
3/18/15
9/8/15
12/7/15
2/27/14

78.18
88.10
81.75
84.97
82.07
42.77

No
No
No
Yes
No*
No

0

Negative

1

3

2015

79.68
63.61
51.06
79.40
71.16
63.05

No
No
No
Yes
No
No

0

Negative

1

3

2015

82.25
82.44
80.46
53.93

No
No
No
Yes

0

Negative

1

3

2015

F
F
F
F
F
F

6.4
6.8
6.8

F
F
F
F
F
F

5.4
6.8
6.8

F
F
F
F
F
F

5.4
6.8
6.8

11.8

10/8/14
2/12/15
3/18/15
9/8/15
11/24/15
2/27/14

F
F
F
F

12.4
12.8
12.8
4.8

10/8/14
2/10/15
3/18/15
2/27/14

4.8

4.8
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Patsy
Patsy
Patsy
Patsy
Loretta
Loretta
Loretta
Loretta
Tammy
Tammy
Tammy
Norma
Norma
Norma
Norma

Athena
Athena
Bean
Bean
Dixie
Dixie
Dixie

Black ButteSDSU
SDSU
SDSU
SDSU
Black Butte SDSU
SDSU
SDSU
SDSU
Black Butte
Black ButteSDSU
SDSU
Black Butte
Black ButteSDSU
SDSU
SDSU
SnowstormsSDSU
SDSU
SnowstormsSDSU
SDSU
Snowstorms
SnowstormsSDSU
SDSU

F
F
F
F

5.4
6.8

10/8/14
2/21/15
10/6/15
10/27/15

80.86
NA
75.30
NA

No
No
No
Yes

F
F
F
F
F

6.4
6.8

5.1

10/8/14
2/21/15
10/6/15
10/27/15
7/3/14

87.49
87.61
82.11
82.99
89.92

Yes
No
No
Yes
Yes

F
F
F

5.4
7.8
10.8

10/8/14
2/20/15
2/27/14

86.10
81.56
45.12

No
No
No

F
F
F

11.4
11.8
12

10/8/14
2/20/15
5/20/15

80.64
88.19
NA

No
No
No

F
F

6.6
6.8

77.68
57.97

F
F
F

4.6

F
F

9.6
9.8

12/9/14
3/18/15
12/9/14
7/15/15
11/5/12
12/9/14
3/18/15

50

Intermittent

5

3

2015

Intermittent

5

3

2015

50

Intermittent

5

3

2015

0

Negative

5

3

2015

No
Yes

9

2

2015

70.82
63.84
57.58

Yes
Yes
Yes

9

2

2015

50.86
54.10

Yes
No

2

2015

9
100

Chronic
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SnowstormsLady
SDSU
Lady
SDSU
SnowstormsLolita
SDSU
Lolita
SDSU
SnowstormsPearl
SDSU
Pearl
SDSU
SnowstormsPenny
SDSU
Penny
SDSU
SnowstormsReba
SDSU
Reba
SDSU
Tizzy
Snowstorms
SnowstormsTizzy
SDSU
Tizzy
SDSU
SnowstormsX-Factor SDSU
X-Factor SDSU
Aldo
SnowstormsSDSU
Aldo
SDSU
Pink

F

Pink
Pink
Olive

Snowstorms
SnowstormsSDSU
SDSU
Snowstorms

F
F

1.6

F
F

6.6

F
F

4.6

F
F

4.6
4.8

F
F
F

1.6
1.8

F
F

7.6

F
F

6.6

M
M

3.6

F
F

12/9/14

76.99
79.98

No
Yes

9

2

2015

70.00
66.05

No
Yes

9

2

2015

86.28
83.86

No
Yes

9

2

2015

56.30
57.88

No
Yes

9

2

2015

-0.77
34.38
55.52

No
No
Yes

9

2

2015

9

2

2015

65.68
74.20

No
No

72.80
66.96

Yes
No

9

2

2015

67.90
70.75

I-Yes
Yes

9

2

2015

7/15/15
12/1/15

63.91

Yes
11

2

2016

7/30/15
12/9/14
7/30/15
12/9/14
7/16/15
12/9/14
3/18/15
12/9/14
3/18/15
8/30/11
12/9/14
7/16/15
12/9/14
7/30/15

9.7

12/9/14

2/1/17
12/1/15

I-Yes
41.65

Yes

100

Chronic
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Diablo
Diablo

SnowstormsSDSU
SDSU
Snowstorms
SnowstormsSDSU
SDSU
Snowstorms
SnowstormsSDSU
SDSU

Jax
Axel
Stevie
Stevie
Asotin
Asotin
Asotin
Dillinger
Dillinger
Dillinger

SDSU
SDSU
SDSU
SDSU
Asotin
Asotin-SDSU
SDSU
Asotin-SDSU
SDSU
SDSU

Olive
Olive
Nana
Nana
Nana
Diablo

F

8.7

2/1/17

F

2.7

12/1/15

F

2.7

2/1/17

F

6.7

12/9/14

F

6.7

2/1/17

M
M
M
M
M
M
M
M
M
M

0.8
2
0.8
1.5
2
2.5
2.7
3

10/30/14
10/30/14
2/28/14
5/27/15
2/26/14
11/11/14
5/20/15
11/11/14
2/5/15
5/20/15

I-Yes
44.85

11

2

2016

100

Chronic

11

2

2016

100

Chronic

11

2

2016

No
I-Yes

50.81
86.21
83.84
62.93
79.62
28.97
60.44
-2.99
4.68
9.90

Chronic

Yes
Yes

82.80

100

No
No
Yes
No
Yes
No
No
No
No
No

2014
2014
2014
2015

2015
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CHAPTER 3: UNILATERAL AND BILATERAL RESPIRATORY DISEASE
SAMPLING OF BIGHORN SHEEP CARRIERS: IS COLONIZATION OF NARES
EQUAL?

This chapter is being prepared for publication and was coauthored by Thomas E. Besser,
Daniel P. Walsh, E. Frances Cassirer, and Jonathan A. Jenks.
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ABSTRACT
Infectious respiratory disease has long been identified as the cause historical
declines and extirpations of bighorn sheep (Ovis candensis), and Mycoplasma
ovipneumoniae (Movi) is the primary pathogen inducing disease and mortality. Sampling
for Movi often entails collecting multiple nasal swabs, but sampling and handling
protocols may vary. Comparison of Movi detection rates associated with protocols that
conduct unilateral or bilateral sampling of the nares and/or collect multiple swabs has not
been described. Therefore, the primary objective of this study was to inform field
sampling techniques for reliable disease surveillance of bighorn sheep populations by
conducting these evaluations. We selected captive adult bighorn sheep with known Movi
carrier histories to describe the probability of Movi detection using unilateral and
bilateral sampling of the nares and the effects of taking multiple samples. The overall
Movi mean detection probability for bilateral upper respiratory samples was 0.18 higher
(95% CI = 0.10–0.26) than unilateral samples. Movi detection probability decreased as
consecutive multiple samples were taken, particularly for unilateral samples, but was not
statistically significant. We documented complete or near unilateral Movi colonization in
27% (n = 3) of the bighorn sheep used in our study, which to our knowledge, is the first
study to document this. Wildlife managers should ensure sampling protocols explicitly
require bilateral nasal swabs for Movi PCR analyses. Although the first sample taken
appears to have the highest Movi detection probability, multiple samples may be taken.
There may be a reduction of detection probability from samples collected later in the
sampling process, however, so managers who need to collect multiple nasal samples for
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various management or research needs should prioritize samples for analysis reflective of
the order in which they were collected.
INTRODUCTION
Wildlife disease investigations require reliable field sampling techniques and
subsequent laboratory evaluations of infectious pathogens. Wildlife managers use the
results of accepted diagnostic assessments to make inferences for disease management
actions. However, successful disease surveillance may be vulnerable to imperfect
diagnostic tests (i.e., detection probability <1). A non-detection may arise from the target
pathogen truly not being present during the investigation or may result from the pathogen
being present but not being detected (i.e., false negative; McClintock et al. 2010, Walsh
et al. 2012). A false negative for targeted infectious pathogens may have severe
implications for wildlife disease control measures. Further, wildlife disease surveillance
can be inherently challenging due to logistical and financial constraints, particularly when
retesting free-ranging individuals (Garwood et al. 2020). Therefore, it is imperative to
understand the impacts of survey protocols on the performance of diagnostic tests by
conducting carefully controlled scientific investigations to determine the most efficient
and effective protocol for pathogen detection (Stallknecht 2007, Ryser-Degiorgis 2013,
Walsh et al. 2016).
Infectious respiratory disease has long been identified as the cause of bighorn
sheep historical declines and extirpations (Shillinger 1937, Cassirer et al. 2018). Bighorn
sheep respiratory disease typically manifests as prolonged periods of disease, often with
high juvenile and sporadic adult mortality (Manlove et al. 2014, Smith et al. 2015).
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Infectious respiratory disease is the primary impediment for bighorn sheep recovery
(Besser et al. 2012, Cassirer et al. 2018).
Historically, investigators have grappled to explain etiological agents causing
fatal polymicrobial respiratory disease in bighorn sheep. Advances in cultureindependent diagnostics (i.e., polymerase chain reaction, PCR) allowed investigators to
identify the primary pathogen affecting bighorn sheep. Using PCR assessments, Besser
et al. (2008) described Mycoplasma ovipneumoniae (Movi) as the first pathogen to
invade the lower respiratory tract. Failure of mucociliary clearance caused by Movi in
the upper respiratory tract predisposes infected animals to secondary pathogens (Besser et
al. 2008, Besser et al. 2012, Besser et al. 2013). A growing body of experimental and
empirical data support that Movi is the primary pathogen causing infectious respiratory
disease in bighorn sheep (Cassirer et al. 2018). For this reason, our study focuses on this
agent.
The incidence of imperfect detection of infectious pathogens in wildlife studies
has been reviewed for a variety of taxa (McClintock et al. 2010, Lachish, et al. 2012)
including recent investigations summarizing variation in detection probability of
infectious pathogens affecting bighorn sheep (Ovis canadensis; Walsh et al. 2012, Walsh
et al. 2016, Butler et al. 2017). Swabbing the nasal cavities is the preferred sampling
methods for Movi detection (Fox et al. 2015, Butler 2017). Imperfect detection and the
power to detect pathogens affecting bighorn sheep may occur due to variation in disease
sampling protocols and in the handling of nasal swabs (Butler et al. 2017). Bighorn
sheep respiratory disease sampling protocols typically call for collecting bilateral nasal
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samples (Drew et al. 2014), but Movi detection rates and probability for unilateral and
bilateral samples have not been reported.
Further, due to logistical constraints on resampling wild animals, multiple
samples are frequently collected to provide data for multiple research efforts, temporally
monitor disease status for individuals and populations, establish and develop sample
banks, and to inform management decisions. Under normal sampling protocols,
investigators typically collect 1 to 4 bilateral nasal swabs per individual (Drew et al.
2014, Butler et al. 2017). To our knowledge, however, potential variation for detection
probability associated with collecting multiple nasal samples and possible PCR signal
decay or exhaustion in serial samples for Movi have yet to be reported. Further, research
indicates intranasal deposition of various size particles during respiration exist in
different location within the nasal cavity (Keck et al. 2000, 2001). This has not been
investigated for Movi in bighorn sheep.
We selected captive adult bighorn sheep with known Movi carrier histories to
describe the probability of detection of this pathogen under various common sampling
protocols. Specifically, we review the potential effects of Movi detection probability
based on presumed pathogen signal decay associated with collection of multiple swabs
from an individual animal, anatomical location of pathogens (anterior vs posterior), and
differential pathogen colonization of nares. The primary objective of this study is to
inform field sampling techniques to ensure efficient and rigorous disease surveillance of
bighorn sheep populations.
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METHODS
Study Area
The study was conducted at the South Dakota State University (SDSU) Captive
Wildlife Research Facility in Brookings, South Dakota (44°20´ N, 96°47´ W) on 11 adult
bighorn sheep transported from free-ranging populations in Washington (n = 6; Asotin
herd n = 5, Black Butte herd n = 1), Oregon (n = 3; Lostine herd), and Nevada (n = 2;
Snowstorm herd; Fig. 1).
Temperature at the study site ranges from -29°C–38°C with a mean annual
temperature of 8°C (Spuhler et al. 1971). Mean regional precipitation ranges from 33–
63.5 cm, including snowfall of 63.5–114 cm (Spuhler et al. 1971). The prevailing wind
direction is from the south in the spring and the north-northwest during the winter. Wind
speeds can exceed 80.5 km/h; however, the average annual wind speed in the region is
17.7 km/h (Spuhler et al. 1971).
Captive animals were provided fresh alfalfa-grass mixed hay, pelleted soybean
hulls, water, and loose mineral ad libitum daily. Capture, transport, daily care and animal
sampling protocols were reviewed and approved by the SDSU Institutional Animal Care
and Use Committee (Number 14-076A). Captive animal care met or exceeded the
recommendations from the Sikes and Animal Care and Use Committee of the American
Society of Mammalogists (2016).
Microbiological Sampling
Based on known exposure and carrier histories, we randomly selected captive
individuals presumed to be carriers for our study. Prior to capture, we permanently
marked single polyurethane culture swabs (BD CultureSwabTM EZ System) with 8

133
equally spaced sections along the length of swab shaft and immediately replaced them
into the swab tube. We pre-labeled swab tubes with individual sheep identification, naris,
and swab number (e.g., “L1–8” and R1–8”; Fig. 2). To capture adults for sampling, we
administered chemical immobilizing agents (BAM; 0.43 mg/kg butorphanol, 0.29 mg/kg
azaperone, 0.17 mg/kg medetomidine, Wildlife Pharmaceuticals) intramuscularly using a
CO2 powered dart projector (Pneu-dart, Williamsport, PA, USA).
We ensured samples were collected in sequential order as presented on premarked swab tubes. We used one timekeeper, who operated a stopwatch and verbally
called out time (seconds passed) when sampling, and one sample collector throughout our
study. We considered anterior and posterior swab samples to reflect marks 1–4 and 5–8,
respectively (Fig. 2). To initiate Movi detection samples, we simultaneously started a
stopwatch and inserted a single polyurethane culture swab halfway (to the 4th mark) for
anterior or fully (to the swab handle or 8th mark) for posterior samples into the specified
naris. As the stopwatch operator verbally indicated the time, the sample collector rotated
the swab shaft while ensuring gentle contact with the mucosal tissue of the nasal wall and
withdrawing the swab with circular motions to ensure each marked section of the swab
was withdrawn at 1 second intervals (4 seconds total).
We stored all samples at 4°C until the next day when we shipped all swabs
overnight to Dr. Thomas Besser’s laboratory at Washington State University (Pullman,
WA, USA). We conducted laboratory assessments of sequential nasal swabs by
extracting and amplifying Movi deoxyribonucleic acid (DNA) using realtime polymerase
chain reaction (PCR) techniques (McAuliffe et al. 2003, Besser et al. 2008, Cassirer et al.
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2017). We considered a sample positive for Movi if fluorescence generation surpassed
the threshold on or before the 36th of 40 PCR cycles.
Statistical Analysis
We used Bayesian logistic regression implemented through Nimble (NIMBLE
Development Team 2018) in Program R (R Core Team 2018) to investigate the
probability of detecting Movi from multiple nasal swab samples. We investigated several
different variables that we believed could affect detection rates. The first covariate of
interest was whether the sample was collected from the anterior or posterior of the nasal
cavity based on swab insertion depth. The second predictor variable was the order in
which a swab was collected. This was to assess if detection probability decreased with
multiple sampling events (i.e., depletion of pathogen). Thus, the linear model we used
for this analysis was:
logit(pi, j, k) = β0 + βloc xi, j, k + δj ,
where pi,j is the probability of detecting Movi using the jth-ordered swab from the kth
sampling (anterior vs. posterior) of the ith individual, β0 is the intercept term, βloc is the
effect of sampling from the anterior of the nasal cavity, xi, j, k is an indicator of sampling
from the anterior of the nasal cavity, and δj is the effect of being the jth-ordered swab. We
modeled the observed detections as Binomial random variables:
yi, j, k ~ Binomials (pi, j, k) .
We specified diffuse Normal (0, 100) prior distributions for β0 and βloc. We used
an intrinsic conditionally auto-regressive prior for δj using a Normal distribution:
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Pr (δj |δ-j ,τ) ~ N (

1
∑ δl , Mτ) ,
M
l∈Λ

where δ-j was all of the swabs except the jth-ordered swab, M was the number of
neighboring swabs for the jth-ordered swab, 𝛬 was the set of all swabs that were
neighbors of the jth-ordered swab (e.g., swabs number 1 and 3 are neighbors for swab 2),
and τ was the precision term. We specified a Gamma (1, 1) hyperprior for this precision.
We enforced a sum-to-zero constraint for 𝛿 .
We were also interested in comparing the impact of sampling both nares over
sampling a single naris on the Movi detection probability, so we conducted the above
analysis twice. In the first analysis, for each individual, we treated each swabbing of a
naris as independent sampling events using the model described above. In the second
analysis, we combined the detection results of sampling each naris into a single response
for each individual using the model described above (i.e., if it was detected in at least one
naris, we considered it detected). We then reran the above model using the combined
results. Finally, we compared the difference in the detection probability estimates
between sampling a single naris compared to both nares.
RESULTS
The median number of pooled detections per individual was 13 (range = 4–16)
with an overall proportion of detections = 0.81. Approximately half (45%; n = 5) of all
individuals in our study reflected perfect detections (i.e., all samples were positive) in
both nares (Fig. 3). The overall Movi mean detection probability for pooled bilateral
upper respiratory samples was 0.18 higher (95% CI = 0.10–0.26) than unilateral samples.
Movi detection probability attributed to sample order decreased as consecutive multiple
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samples were taken, particularly for unilateral samples (unilateral mean detection
probability range = 0.67–0.84), but differences were not statistically significant (Fig. 4;
i.e., all 95% CI of the differences include zero) with the maximum difference, -0.11 (95%
CI = -0.29–0.072) occurring between the last and first sample collected. Overall mean
detection probability was higher for anterior (0.80) as compared to posterior (0.73) nasal
samples, but this is finding is not statistically significant (Fig. 4).
Interestingly, approximately 20% (n = 2; Sheep IDs G57, Y33) of individuals
consistently presented unilateral Movi infection (all 8 samples were positive detections)
while the other naris seemed completely uninfected (all 8 samples were non-detections;
Fig. 3). We based our conclusion that these were unilateral infections rather than a
failure to detect the pathogen’s presence because, given our estimated detection rates,
there was only a 0.0000136 probability (95% CI = 7.60 e-07–5.99 e-05) the naris was
infected and not detected given our sampling effort. The mean Movi CT for the infected
naris for G57 and Y33 was 28.29 (range = 26.90–28.99) and 27.80 (range = 26.49–
28.75), respectively, suggesting Movi colonization was relatively high in one naris but
completely absent in the other. An additional individual (Sheep ID Y56) was weakly
positive (Movi CT = 35.60) in the first posterior sample, but indeterminate (Movi CTs =
36.28 [swab Left1] and 37.34 [swab Left3]) or negative (Movi CT = 40 [swab Left2,
Left4, Left6–8]) in all other samples for that naris (Fig. 3).
We observed variable detection of Movi from some unilateral samples, but these
observations primarily resulted from 2 individuals (Sheep IDs G20 and W7; Fig. 3).
Sheep G20 presented consistently strong positive Movi PCR signals in all unilateral
samples (Movi CT range = 18.15–20.39) in which Movi was detected, but Movi was not
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detected in right unilateral samples 5, 6 and 8 (Movi CT = 40). Comparatively, Sheep ID
W7 presented weak positive Movi PCR signals in one naris (Movi CTs = 35. 75 [swab
Left1], 35.60 [swab Left3], 34.76 [swab Left5]) but consistently stronger positive PCR
signals (Movi CT range = 22.12–32.26) in the other naris (Fig. 3).
One individual, Sheep ID Y60, was considered a subclinical chronic Movi carrier.
Sheep Y60 was weakly positive (Left Movi CT = 35.28, 32.51; Right Movi CT = 35.76,
35.20) in the first and second unilateral swabs and negative (Movi CT = 40) in all
subsequent samples. This may have reflected the only potential case where collection of
multiple swabs affected the Movi PCR signal. The probability that the pathogen was
present after the first two samples were collected from each naris and then not detected in
the subsequent 6 samples based on our estimated detection rates was extremely low (i.e.,
0.000376; 95%CI = 4.63 e-05–1.22 e-03), indicating potential impacts of multiple sample
collections. Additionally, the overall proportion of Movi detection for bilateral samples
was 0.25 for this individual, which is the lowest in our study. Samples 3–8 from this
individual were also the only instance where we were not able to detect Movi in samples
from at least one naris when using bilateral sampling (Fig. 3).
DISCUSSION
This is the first study to evaluate the impacts of protocols that rely on unilateral or
bilateral sampling of the nasal cavities and collect serial samples on the detection
probability of Movi in bighorn sheep. Although unilateral nasal samples may produce a
reliable result for a given individual, our results demonstrate the bilateral procedure
increases the likelihood of pathogen detection (18% overall larger mean detection
probability) when collecting 8 nasal swabs (Fig. 4). Previous investigations report

138
bilateral respiratory samples are more likely to be positive than unilateral samples for
human respiratory disease (Jonker et al. 2012), but to our knowledge, these studies have
not previously occurred for free-ranging or domestic animal populations.
An unexpected and previously undocumented finding of our study is the unilateral
Movi colonization of nares in approximately 20% (n = 2) of the bighorn sheep
investigated. An additional animal had near unilateral colonization (1 unilateral sample
was weakly positive, all others failed to detect Movi; Fig. 3). Additionally, these 3
animals had relatively strong positive PCR signals for all samples in the other naris
indicating infection of that naris was relatively strong. Although we did not include
replicate sampling events for individuals, 1 of the 2 bighorn sheep (Sheep ID G57) was
sampled on multiple days. During the initial sampling on 11 October 2016, the individual
displayed unilateral (left naris) infection; during the second sampling on 17 November
2016, we detected bilateral infection with some presumed false negatives in the left naris
and all positives in the right naris; and during the final sampling on 23 January 2017, we
noted unilateral (left naris) infection. Although anecdotal, this suggests unilateral Movi
colonization documented in our study is not stable. Additional studies are warranted to
describe the underlying process that leads to unilateral nasal colonization in infectious
respiratory disease processes.
Unilateral Movi colonization documented in our study may be driven by an
underlying complex host-pathogen interaction and co-infections. Fox et al. (2015)
documented Movi detection probability in sinus lining tissue was strongly associated
with the severity of sinus tumors and suspected sinus lining thickening could maintain
pathogenic bacteria in the upper respiratory tract. Further, bilateral and unilateral sinus
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tumors were documented in 80% and 20%, respectively, of affected bighorn sheep in
Colorado (Fox et al. 2015). Purulent otitis media has been associated with Movi-induced
pneumonia in bighorn sheep (Besser et al. 2008) and other Mycoplasma respiratory coinfections in domestic hosts (Maeda et al. 2003, Lima et al. 2016). Otitis media may also
present unilateral infections in hosts but may be less frequent and less severe than
bilateral middle ear infections, although overlap of clinical symptoms is common
(Leibovitz et al. 2007, Ackermann et al. 2017).
Wild and domestic animal disease studies have long recognized imperfect
pathogen detection in most sampling and diagnostic tests (MacKenzie et al. 2002, Fablet
et al. 2010, Walsh et al. 2016, DiRenzo et al. 2017); however, the effect of collecting
multiple samples on detection probability and subsequent PCR signal decay had not been
reported. Although not statistically significant, our results indicate mean detection
probability may have decreased as multiple samples were collected, particularly for
unilateral swabs, but to our knowledge has not been reported elsewhere. In
approximately 90% of bilateral samples, Movi was detected in all samples for all known
Movi carriers in our study. However, 1 known subclinical Movi chronic carrier
presented repeated non-detections in serial samples. If investigators failed to record the
order in which samples were sequentially collected and randomly selected bilateral
samples 3–8, they would have yielded a false negative for this individual.
The diagnostic procedures for Movi used in this study resulted in a high overall
detection probability for 8 serial upper respiratory samples, which is within agreement
with previous studies (Walsh et al. 2016, Butler et al. 2017). It is imperative that disease
ecologists have reliable diagnostic tools, particularly for the management of disease-
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limited wildlife populations such as bighorn sheep. Laboratories that offer Movi
diagnostics consistently provide reliable results, and median agreement of pooled Movi
samples across all of these laboratories was 0.90 (Walsh et al. 2016). Walsh et al. (2016)
reported Movi CT values near the detection threshold (i.e., weak positive and/or negative
samples) attributed to disagreements within and among laboratories. Individual variation
of weakly positive animals (i.e., Movi CT values near the detection threshold) may
attribute to the lack of pathogen detection experienced in our study. Our study
anecdotally agrees with previous research efforts that conclude pathogen detection
probability is related to host infection intensity (DiRenzo et al. 2017), but additional
investigations are needed.
MANAGEMENT IMPLICATIONS
Infectious respiratory pathogen sampling methods should ensure repeatability and
data quality. Upper respiratory nasal swabs for laboratory diagnostics are generally noninvasive and are the premier sample for Movi detection in bighorn sheep. Wildlife
managers should ensure sampling protocols explicitly require bilateral nasal swabs for
Movi PCR analyses as this increases overall detection probability of this pathogen.
Multiple bilateral nasal samples may be collected, and samplers should particularly
ensure the anterior portion of nasal cavity (or front half of the swabs) is swabbed
adequately. When collecting more than 1 sample, however, managers should record the
order at which samples were taken. The first bilateral nasal sample should be the priority
for laboratory assessments, and all other replicate samples could be banked for reanalysis at a later date.
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Figure 1. Wild bighorn sheep source herds selected for translocation to the South Dakota
State University Captive Wildlife Research Facility, Brookings, South Dakota.
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Figure 2. Permanently marked single polyurethane culture swabs with 8 equally spaced
sections along the length of swab shaft. The 4th permanent mark represents the start and
stop of the anterior and posterior samples. Swab numbers 1–4 were anterior samples and
swabs 5–8 were posterior samples.

Anterior

Posterior
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Figure 3. Mycoplasma ovipneumoniae detection history for 8 unilateral nasal swabs collected in left and right naris by
individual bighorn sheep with known carrier histories used in our study. We considered a sample positive for Movi if
fluorescence generation surpassed the threshold on or before the 36th of 40 polymerase chain reaction (PCR) cycles.
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Figure 4. Detection probability of Mycoplasma ovipneumoniae (Movi) in multiple (1–8) nasal swabs of captive bighorn sheep
with known carrier histories. Swabs were collected and analyzed based on order of sample collection (1–8), anatomical
location (anterior (1–4) or posterior (5–8). We report unilateral swabs separately and then pooled ordered unilateral swabs to
establish bilateral ordered samples (e.g., Unilateral sample Left 1 and Right 1 were pooled for Bilateral 1 sample). The mean
Movi detection probability is presented as a circle and 95% credible intervals for multiple nasal samples are presented.

